data_2ytb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ytb _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? . . . . . 0 C--O 1.231 0.081 0 CA-C-O 121.58 0.705 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -25.27 28.99 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 0.0 112.365 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -84.96 101.12 12.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.954 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 31.7 ttp85 -137.83 111.16 7.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -66.7 129.49 40.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -91.78 -9.32 44.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -76.38 -36.96 57.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.15 -32.76 4.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.96 46.63 2.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -108.54 -179.38 3.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.32 141.4 33.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.066 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -134.13 153.51 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.15 -28.47 25.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -123.52 162.78 22.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -53.1 9.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.97 -46.3 26.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 m -51.63 -38.6 55.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.87 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.7 tp -71.42 -32.26 68.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.955 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.5 mt -60.95 -32.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.6 t -77.9 -10.74 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -94.05 -32.51 13.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 55.4 mt -56.72 -21.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.184 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -55.09 -26.14 35.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.5 m -82.51 -26.07 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -95.96 -74.07 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.153 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.596 0.713 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -24.42 29.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.232 . . . . 0.0 112.367 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -86.49 100.71 12.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -136.48 111.39 8.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.5 t -67.43 129.93 41.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.52 -9.31 41.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.838 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -76.12 -36.68 58.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.06 -32.72 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.15 50.23 1.94 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.75 -179.01 3.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.11 140.21 34.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -131.02 151.45 51.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.942 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.79 -29.25 29.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.823 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -123.19 164.91 17.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.17 -53.05 8.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.11 -45.73 26.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.49 -39.4 57.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.844 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 12.2 tp -71.03 -32.9 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.8 mt -60.03 -32.45 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.0 t -79.12 -10.88 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -94.01 -32.88 13.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.862 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 58.0 mt -56.39 -21.76 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -55.21 -25.93 36.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.2 m -82.42 -25.6 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -97.66 -74.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.184 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.552 0.691 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -24.74 29.69 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 0.0 112.368 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -86.02 100.61 12.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -136.75 111.31 8.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.8 130.65 43.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -92.48 -10.22 38.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.865 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -75.64 -36.94 60.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.88 -32.9 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.17 47.84 2.34 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -110.09 -179.2 3.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.799 0.333 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.66 140.12 34.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.079 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -131.84 151.68 51.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.4 -29.03 28.48 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.831 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -123.18 164.77 18.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -53.08 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.23 -45.55 27.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.537 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.63 -39.38 57.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.848 0.356 . . . . 0.0 110.835 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.5 tp -71.01 -32.91 69.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.7 mt -60.0 -32.62 50.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.83 -10.79 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.094 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -94.18 -32.35 13.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 56.0 mt -56.45 -21.68 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -55.52 -25.73 39.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.1 m -82.5 -24.88 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -98.5 -74.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.105 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.543 0.687 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -24.58 29.39 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.685 2.257 . . . . 0.0 112.36 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -86.19 100.63 12.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -136.04 111.3 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.851 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -67.32 130.15 42.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -92.5 -9.26 42.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -76.43 -37.44 57.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.43 -32.77 4.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.04 49.81 2.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.91 -179.05 3.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 0.0 110.935 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.82 139.75 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -130.61 151.43 51.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 83.7 p -83.1 -28.93 29.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.78 163.8 20.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.937 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -76.03 -53.12 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.84 -45.87 25.25 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.455 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.52 -39.11 57.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 0.0 110.808 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 12.3 tp -71.36 -33.34 69.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.7 mt -59.68 -32.08 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.7 t -79.78 -10.87 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -94.04 -33.19 13.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 55.8 mt -56.51 -21.69 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -55.36 -25.86 37.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.1 m -82.72 -25.09 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.113 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -97.53 -74.19 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.579 0.704 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -24.51 29.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 0.0 112.355 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -86.5 100.54 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.43 111.34 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.5 t -67.47 130.18 42.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -92.56 -9.91 39.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -75.51 -36.6 60.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.17 -32.76 4.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.04 50.11 1.97 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -113.59 -179.02 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.85 140.37 34.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.075 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -131.07 151.42 51.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 38.7 t -83.05 -29.03 29.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -123.17 164.8 18.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -53.22 8.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.921 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.28 -45.32 28.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.49 -39.67 58.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.877 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 12.7 tp -70.89 -33.13 70.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.915 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.3 mt -59.7 -32.54 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.23 -10.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -94.02 -32.64 13.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.856 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 59.0 mt -56.41 -21.79 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -55.4 -25.79 37.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.6 m -82.43 -25.08 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -98.48 -74.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.162 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.56 0.695 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -23.99 29.94 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.693 2.262 . . . . 0.0 112.339 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -86.91 103.59 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -138.05 110.59 7.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -66.5 130.38 42.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.48 -9.29 41.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.852 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -76.66 -37.39 56.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -119.66 -32.94 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.81 49.02 2.19 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.455 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -111.67 -178.97 3.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.36 141.18 35.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.09 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -132.32 151.35 51.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.15 -28.98 29.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -123.31 163.72 20.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -53.16 8.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.29 -45.57 28.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.3 m -51.52 -39.24 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.862 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.3 tp -71.16 -33.07 69.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.958 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.1 mt -59.89 -32.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.089 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.35 -10.87 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -94.17 -32.33 13.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.832 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 58.7 mt -56.8 -21.56 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.108 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -55.4 -25.72 37.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.3 m -82.77 -24.96 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.079 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -98.34 -75.0 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.571 0.701 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -24.06 30.06 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.642 2.228 . . . . 0.0 112.394 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -87.14 100.26 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -135.05 111.36 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -67.25 130.37 42.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.49 -9.29 41.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -76.6 -37.7 56.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.17 -32.8 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.41 50.45 2.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.458 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.58 -178.99 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.49 139.52 35.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -130.01 149.91 51.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 98.1 p -81.41 -29.57 33.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.19 164.49 18.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -76.55 -53.74 7.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.64 -45.68 23.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.493 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.3 m -51.5 -38.74 55.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.942 0.401 . . . . 0.0 110.887 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 15.0 tp -72.23 -32.83 67.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 18.3 mt -60.34 -30.63 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.8 t -81.39 -10.84 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -93.63 -32.85 13.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.6 mt -56.66 -21.57 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -54.93 -26.0 33.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.7 m -82.45 -26.56 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -96.51 -74.82 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.518 0.675 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -23.55 30.64 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.708 2.272 . . . . 0.0 112.309 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -87.72 100.34 12.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.79 111.45 9.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -67.54 129.89 41.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.46 -9.24 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -76.23 -36.87 58.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.04 -32.84 4.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.85 50.53 1.93 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -178.83 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.333 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.06 140.04 34.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.067 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -129.99 150.16 51.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.83 -29.59 35.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -123.26 165.37 17.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -52.78 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.31 -45.57 28.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.52 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.69 -38.84 56.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.862 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 12.4 tp -71.5 -32.56 68.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.93 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.0 mt -60.45 -32.27 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.3 t -80.2 -10.7 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -92.93 -33.87 14.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 55.0 mt -58.23 -20.49 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -55.27 -25.42 33.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 11.5 m -85.24 -24.89 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.121 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -93.86 -74.71 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.139 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.592 0.71 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -15.99 37.16 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.677 2.251 . . . . 0.0 112.32 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -95.52 99.73 11.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -135.09 111.64 9.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -66.94 131.19 45.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -92.45 -13.2 30.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -72.21 -36.47 69.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.7 p -120.21 -32.76 4.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 94.54 50.81 2.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.472 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -114.12 -179.24 3.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.771 0.32 . . . . 0.0 110.926 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -138.79 137.77 36.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -127.87 144.85 51.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.8 t -75.83 -31.28 59.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -123.12 164.87 17.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -76.25 -52.59 9.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.2 -45.17 27.48 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.499 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -39.49 58.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.848 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 13.9 tp -71.1 -33.79 70.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.7 mt -58.89 -31.92 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.98 -10.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.169 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.0 t60 -93.42 -31.9 14.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.885 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 58.2 mt -56.34 -21.98 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -55.51 -25.64 38.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.0 m -81.98 -25.62 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -98.69 -74.95 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.846 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.615 0.721 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -15.63 37.06 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.658 2.239 . . . . 0.0 112.367 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -96.65 99.6 11.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.79 111.59 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.87 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.7 t -67.44 131.08 44.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -92.42 -12.64 31.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -72.78 -36.86 67.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.8 p -119.93 -32.57 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.854 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 94.52 50.88 2.09 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -114.09 -179.27 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.04 136.44 33.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -126.52 146.97 49.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.59 -30.64 52.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.59 165.36 16.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -52.92 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.21 -45.38 27.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.467 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.55 -39.55 57.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.902 0.382 . . . . 0.0 110.82 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.99 -33.16 70.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.5 mt -59.6 -32.37 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.0 t -80.38 -10.73 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -93.26 -32.16 14.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 58.6 mt -56.58 -21.78 13.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -55.5 -25.71 38.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.5 m -82.3 -25.03 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.132 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -98.95 -75.07 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.562 0.696 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.77 -24.82 29.2 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.675 2.25 . . . . 0.0 112.309 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -85.73 100.62 12.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -136.12 111.43 9.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 10.1 t -67.76 130.35 42.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.34 -10.16 39.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -75.28 -36.67 61.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.33 -33.1 3.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.54 48.42 2.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -111.34 -178.8 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.788 0.328 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.71 139.11 32.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -130.14 152.65 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 27.4 t -83.77 -29.04 27.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -123.41 163.86 20.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.3 -52.66 9.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.11 -46.23 27.0 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 m -51.66 -38.62 55.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.6 tp -71.43 -32.17 68.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.7 mt -60.95 -33.03 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.11 -10.8 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -93.32 -36.48 12.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.75 -19.92 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -23.92 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 11.5 m -87.75 -23.8 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -91.14 -74.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 -179.91 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.578 0.704 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -26.09 28.13 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.706 2.27 . . . . 0.0 112.339 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -85.14 104.21 14.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.877 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 108.75 5.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -65.34 130.7 44.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.51 -9.74 40.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -76.37 -36.91 57.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.17 -32.89 4.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.4 39.31 3.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.518 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.28 -179.99 4.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 0.0 110.872 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.18 138.46 28.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -133.21 163.96 28.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.7 m -101.9 -21.77 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.855 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -123.58 138.94 54.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -56.53 20.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.68 -45.13 24.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.504 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.41 -39.79 58.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.888 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.3 tp -71.38 -32.4 68.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 17.3 mt -60.89 -31.77 50.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.137 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.9 t -78.33 -10.97 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -94.55 -31.32 13.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 56.5 mt -56.71 -21.59 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.1 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -55.48 -25.82 39.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.2 m -82.17 -25.14 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -98.59 -74.92 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 -179.942 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.589 0.709 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -28.31 25.33 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.71 2.273 . . . . 0.0 112.305 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -82.8 104.58 13.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.36 109.13 5.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.0 130.42 43.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.4 -9.46 41.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -76.6 -36.88 57.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.19 -32.87 4.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.27 40.65 3.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.517 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -101.31 -179.71 4.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.19 139.21 28.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.098 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -133.43 164.44 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.2 m -102.45 -21.65 14.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -123.6 139.57 53.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.94 -56.93 15.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.71 -44.82 23.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.443 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.5 m -51.44 -40.23 58.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.905 0.384 . . . . 0.0 110.825 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.0 tp -71.05 -32.62 69.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.9 mt -60.67 -31.8 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.29 -10.98 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.148 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -94.54 -31.38 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 56.6 mt -57.17 -21.34 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.12 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -55.52 -26.03 40.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.3 m -82.34 -24.53 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.155 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -98.43 -74.71 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.62 0.724 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -27.24 26.97 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.698 2.265 . . . . 0.0 112.38 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -84.13 105.04 14.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -142.53 106.56 4.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.885 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -63.43 129.39 40.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -91.08 -9.4 45.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.56 -37.01 57.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.11 -32.86 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.21 38.81 3.93 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.489 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -98.29 -179.73 4.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 0.0 110.903 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -143.86 138.8 28.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.082 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -133.93 164.15 27.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 5.1 m -102.44 -21.36 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -124.22 141.29 52.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -56.91 16.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.52 -44.96 22.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.519 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.47 -39.95 58.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 110.83 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.5 tp -71.41 -32.27 68.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 17.9 mt -61.15 -31.64 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.8 t -78.54 -10.96 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.075 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -94.19 -31.2 14.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -57.15 -21.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.092 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.7 mtt-85 -55.47 -25.92 39.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.829 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.0 m -82.35 -25.13 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.131 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -97.56 -74.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.595 0.712 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -25.15 29.01 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.705 2.27 . . . . 0.0 112.326 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -86.27 103.82 15.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -141.68 107.19 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 12.3 t -64.9 129.06 38.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.924 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.33 -11.93 39.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -73.0 -37.36 67.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -120.24 -32.93 4.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.6 38.56 3.9 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -98.06 -179.97 4.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.8 137.73 26.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.056 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -133.04 164.06 27.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.98 -21.67 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -123.07 138.81 54.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -56.97 15.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.43 -45.65 22.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.45 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.63 -38.09 53.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 110.842 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 14.0 tp -73.24 -31.02 63.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 18.7 mt -62.88 -30.27 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.0 t -80.03 -10.85 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -93.46 -33.24 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 55.4 mt -59.39 -19.79 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -55.45 -25.0 33.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 12.8 m -86.13 -24.54 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -92.33 -75.05 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.147 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.549 0.69 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -26.19 27.56 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.674 2.249 . . . . 0.0 112.349 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -83.59 101.74 11.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -136.87 111.26 8.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.93 126.09 28.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -88.34 -10.93 47.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -73.01 -38.81 66.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.77 -33.15 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.5 48.1 2.05 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -111.66 -178.64 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.2 140.53 34.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -131.77 153.6 49.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.9 m -87.33 -27.09 23.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -123.58 157.05 34.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -54.68 10.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.97 -45.58 26.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.497 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.5 m -51.98 -36.29 49.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.839 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 13.2 tp -74.86 -31.75 61.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.7 mt -62.65 -27.6 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.26 -10.73 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.09 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -93.9 -36.8 12.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.58 -19.87 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.154 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -59.42 -20.7 57.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.9 m -98.02 8.11 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -114.8 -75.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.571 0.7 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -26.7 27.57 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.738 2.292 . . . . 0.0 112.367 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -84.74 106.36 16.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -142.94 107.0 4.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.4 t -64.53 130.15 42.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.858 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -92.04 -9.52 42.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.847 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -76.44 -36.88 57.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.946 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.32 -32.85 4.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.01 39.83 3.7 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.481 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -100.31 -179.82 4.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.1 140.08 29.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.085 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -134.08 163.87 28.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 71.0 m -100.68 -22.42 14.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.819 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -123.43 144.26 49.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -61.46 -57.29 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -46.94 -44.31 18.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.463 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.5 m -51.63 -40.01 59.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 110.872 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 10.5 tp -72.0 -32.86 67.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 17.9 mt -60.99 -29.43 45.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 19.9 t -81.53 -10.81 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -94.35 -33.66 13.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.9 mt -57.92 -20.61 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -55.33 -25.26 33.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 11.4 m -84.5 -25.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -93.09 -74.71 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.524 0.678 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -25.16 28.79 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.672 2.248 . . . . 0.0 112.349 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -85.81 99.95 11.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -135.09 111.57 9.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.2 t -68.71 128.04 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.57 -12.43 39.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.81 -38.55 70.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -118.82 -32.94 4.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.08 50.35 1.93 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.86 -178.56 3.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.792 0.329 . . . . 0.0 110.928 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.7 139.18 34.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.073 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -129.48 150.71 50.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 56.0 p -82.89 -28.78 29.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.65 162.41 23.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -53.85 8.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.7 -46.07 24.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.482 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.36 -37.58 48.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.901 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.7 -31.7 63.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.928 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 18.9 mt -61.93 -29.11 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 19.8 t -83.43 -10.88 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -95.09 -40.32 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 53.1 mt -57.79 -20.46 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -59.26 -21.19 59.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.4 m -97.46 7.45 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -113.25 -74.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 50.4 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 -179.894 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.587 0.708 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -26.86 27.04 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.708 2.272 . . . . 0.0 112.33 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.19 110.53 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -144.94 104.38 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -62.9 127.25 30.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.58 -9.25 50.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -76.35 -37.26 57.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.36 -32.98 3.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.37 41.55 3.41 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -102.19 -179.35 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.341 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -143.11 142.28 31.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -135.86 162.5 32.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.0 -23.19 16.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -125.82 150.9 47.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.941 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -54.34 24.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.95 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.7 -46.26 24.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.447 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -51.29 -39.54 57.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 110.907 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.6 tp -70.86 -32.03 68.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.951 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 17.0 mt -61.45 -31.94 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.091 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.0 t -78.95 -10.84 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -93.73 -31.89 14.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 57.1 mt -56.7 -21.61 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -54.87 -26.22 34.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.8 m -81.49 -27.12 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.116 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -96.39 -74.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.65 0.738 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -27.13 26.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.671 2.248 . . . . 0.0 112.361 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -82.45 101.61 10.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -136.69 111.26 8.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 16.0 t -69.12 124.51 23.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.71 -11.16 52.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.41 -40.07 67.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.974 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -117.81 -33.2 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.81 48.12 1.99 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.518 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -111.63 -178.73 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.71 140.98 34.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.13 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -132.24 153.22 50.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.3 p -86.5 -27.6 23.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.854 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -123.91 159.66 29.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -72.89 -54.5 8.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.8 -45.96 24.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.466 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.8 m -51.8 -36.24 47.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.917 0.389 . . . . 0.0 110.85 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 14.0 tp -74.92 -32.28 61.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.2 mt -62.36 -26.94 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 19.6 t -84.74 -10.8 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -94.35 -36.74 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.28 -20.03 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -59.32 -20.6 55.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.8 m -98.38 10.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.127 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -117.11 -75.07 0.58 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.36 97.03 1.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 110.898 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.35 178.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 66.51 88.03 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.464 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 51.0 m -157.37 64.72 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.865 0.364 . . . . 0.0 110.846 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.03 139.94 33.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -151.24 114.51 0.65 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 131.09 -46.34 1.08 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.505 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 52.11 54.99 9.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.916 0.389 . . . . 0.0 110.905 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -91.26 156.14 43.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.58 0.705 . . . . 0.0 110.931 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -25.27 28.99 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 0.0 112.365 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -84.96 101.12 12.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.954 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 31.7 ttp85 -137.83 111.16 7.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -66.7 129.49 40.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -91.78 -9.32 44.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -76.38 -36.96 57.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.15 -32.76 4.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.96 46.63 2.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -108.54 -179.38 3.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.32 141.4 33.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.066 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -134.13 153.51 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.15 -28.47 25.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -123.52 162.78 22.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -53.1 9.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.97 -46.3 26.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 m -51.63 -38.6 55.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.87 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.7 tp -71.42 -32.26 68.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.955 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.5 mt -60.95 -32.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.6 t -77.9 -10.74 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -94.05 -32.51 13.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 55.4 mt -56.72 -21.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.184 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -55.09 -26.14 35.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.5 m -82.51 -26.07 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -95.96 -74.07 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.12 151.0 24.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.153 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.79 103.11 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.61 126.61 50.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 110.842 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 52.11 -172.85 0.28 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.514 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 145.77 58.39 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.651 2.234 . . . . 0.0 112.369 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 3.1 p -157.59 34.7 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.81 -172.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 CA-C-O 119.132 -0.816 . . . . 0.0 112.501 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.74 113.43 10.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.906 0.384 . . . . 0.0 110.874 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.56 136.32 2.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.885 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -141.56 -130.9 2.6 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.503 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.29 -26.93 17.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.369 . . . . 0.0 110.915 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.1 m 52.27 41.81 30.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.81 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.51 -93.93 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.493 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -139.14 143.82 14.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.482 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -131.72 168.97 16.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.93 0.395 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -105.29 155.37 37.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.713 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -24.42 29.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.232 . . . . 0.0 112.367 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -86.49 100.71 12.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -136.48 111.39 8.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.5 t -67.43 129.93 41.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.52 -9.31 41.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.838 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -76.12 -36.68 58.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.06 -32.72 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.15 50.23 1.94 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.75 -179.01 3.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.11 140.21 34.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -131.02 151.45 51.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.942 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.79 -29.25 29.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.823 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -123.19 164.91 17.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.17 -53.05 8.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.11 -45.73 26.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.49 -39.4 57.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.844 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 12.2 tp -71.03 -32.9 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.8 mt -60.03 -32.45 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.0 t -79.12 -10.88 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -94.01 -32.88 13.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.862 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 58.0 mt -56.39 -21.76 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -55.21 -25.93 36.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.2 m -82.42 -25.6 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -97.66 -74.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.45 150.99 24.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.184 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.49 103.12 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.501 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.1 t -123.15 148.73 45.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.951 0.405 . . . . 0.0 110.8 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 73.52 172.97 25.76 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.444 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 96.76 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.733 2.289 . . . . 0.0 112.339 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 4.2 m -116.17 163.2 16.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.822 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 2.9 t -152.72 -42.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.843 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.469 -179.958 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.11 80.53 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.896 0.379 . . . . 0.0 110.901 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 67.3 m -123.02 161.76 23.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.839 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 176.35 -140.7 5.17 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.467 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 m 51.95 64.31 1.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 110.881 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.6 p -139.54 56.07 1.66 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.816 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 108.15 160.58 20.51 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.437 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 167.99 79.27 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.484 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.33 -26.85 9.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.861 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -84.08 155.64 63.89 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.552 0.691 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -24.74 29.69 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 0.0 112.368 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -86.02 100.61 12.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -136.75 111.31 8.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.8 130.65 43.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -92.48 -10.22 38.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.865 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -75.64 -36.94 60.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.88 -32.9 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.17 47.84 2.34 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -110.09 -179.2 3.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.799 0.333 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.66 140.12 34.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.079 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -131.84 151.68 51.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.4 -29.03 28.48 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.831 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -123.18 164.77 18.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -53.08 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.23 -45.55 27.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.537 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.63 -39.38 57.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.848 0.356 . . . . 0.0 110.835 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.5 tp -71.01 -32.91 69.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.7 mt -60.0 -32.62 50.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.83 -10.79 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.094 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -94.18 -32.35 13.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 56.0 mt -56.45 -21.68 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -55.52 -25.73 39.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.1 m -82.5 -24.88 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -98.5 -74.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.73 151.08 24.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.105 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.25 103.19 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 44.2 t -122.99 47.77 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.913 0.387 . . . . 0.0 110.869 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -92.98 -167.51 38.95 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -34.8 13.67 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.648 2.232 . . . . 0.0 112.357 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 60.2 m -156.56 -51.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.01 108.85 1.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.842 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.506 179.984 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.89 136.98 52.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 0.0 110.902 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 55.4 m -72.06 -50.56 27.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.872 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.81 142.76 5.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.535 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.9 t -69.04 147.77 51.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 0.0 110.871 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.6 m -112.82 49.08 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.85 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 85.34 175.46 50.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.494 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.63 70.76 1.0 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.477 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.11 112.37 23.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.956 0.408 . . . . 0.0 110.849 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -112.62 155.5 43.78 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.543 0.687 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -24.58 29.39 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.685 2.257 . . . . 0.0 112.36 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -86.19 100.63 12.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -136.04 111.3 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.851 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -67.32 130.15 42.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -92.5 -9.26 42.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -76.43 -37.44 57.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.43 -32.77 4.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.04 49.81 2.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.91 -179.05 3.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 0.0 110.935 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.82 139.75 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -130.61 151.43 51.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 83.7 p -83.1 -28.93 29.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.78 163.8 20.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.937 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -76.03 -53.12 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.84 -45.87 25.25 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.455 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.52 -39.11 57.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 0.0 110.808 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 12.3 tp -71.36 -33.34 69.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.7 mt -59.68 -32.08 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.7 t -79.78 -10.87 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -94.04 -33.19 13.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 55.8 mt -56.51 -21.69 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -55.36 -25.86 37.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.1 m -82.72 -25.09 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.113 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -97.53 -74.19 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.0 151.11 26.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.05 103.16 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.9 t -118.82 -34.96 3.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 0.0 110.873 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -143.07 165.69 26.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 93.83 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.674 2.25 . . . . 0.0 112.349 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 45.9 m -133.96 27.47 3.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 3.5 m 52.11 34.84 15.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 CA-C-O 119.118 -0.823 . . . . 0.0 112.516 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.1 97.3 9.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.856 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.21 128.53 6.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.846 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 141.84 50.73 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.456 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.3 p -130.15 27.88 5.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 0.0 110.893 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.1 m -101.41 173.9 6.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.907 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -104.11 -78.25 1.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.481 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 112.23 41.98 1.02 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.489 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -102.15 -27.72 12.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.943 0.401 . . . . 0.0 110.882 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -75.79 154.8 85.2 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.579 0.704 . . . . 0.0 110.889 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -24.51 29.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 0.0 112.355 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -86.5 100.54 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.43 111.34 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.5 t -67.47 130.18 42.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -92.56 -9.91 39.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -75.51 -36.6 60.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.17 -32.76 4.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.04 50.11 1.97 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -113.59 -179.02 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.85 140.37 34.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.075 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -131.07 151.42 51.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 38.7 t -83.05 -29.03 29.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -123.17 164.8 18.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -53.22 8.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.921 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.28 -45.32 28.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.49 -39.67 58.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.877 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 12.7 tp -70.89 -33.13 70.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.915 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.3 mt -59.7 -32.54 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.23 -10.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -94.02 -32.64 13.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.856 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 59.0 mt -56.41 -21.79 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -55.4 -25.79 37.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.6 m -82.43 -25.08 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -98.48 -74.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.02 151.08 22.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.162 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.33 103.15 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.514 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.3 t -130.94 26.4 4.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.38 . . . . 0.0 110.833 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -111.28 165.76 12.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -48.26 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.64 2.227 . . . . 0.0 112.34 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.27 94.43 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.82 -47.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.834 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.092 -0.838 . . . . 0.0 112.504 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.0 m -80.91 127.56 32.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.3 p -164.7 -175.66 3.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.835 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -165.72 147.21 11.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 31.5 m -97.19 -67.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.878 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.5 m 57.56 72.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 170.89 83.99 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.491 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 157.46 98.57 0.15 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.468 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.29 -25.98 9.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.921 0.391 . . . . 0.0 110.898 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -81.73 155.39 70.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.56 0.695 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -23.99 29.94 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.693 2.262 . . . . 0.0 112.339 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -86.91 103.59 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -138.05 110.59 7.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -66.5 130.38 42.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.48 -9.29 41.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.852 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -76.66 -37.39 56.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -119.66 -32.94 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.81 49.02 2.19 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.455 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -111.67 -178.97 3.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.36 141.18 35.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.09 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -132.32 151.35 51.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.15 -28.98 29.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -123.31 163.72 20.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -53.16 8.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.29 -45.57 28.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.3 m -51.52 -39.24 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.862 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.3 tp -71.16 -33.07 69.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.958 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.1 mt -59.89 -32.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.089 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.35 -10.87 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -94.17 -32.33 13.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.832 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 58.7 mt -56.8 -21.56 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.108 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -55.4 -25.72 37.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.3 m -82.77 -24.96 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.079 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -98.34 -75.0 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.91 151.1 24.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.11 103.08 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.5 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.1 t -123.91 46.55 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.827 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 162.94 -75.64 0.18 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.478 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 97.49 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.674 2.25 . . . . 0.0 112.385 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 13.7 m -104.8 39.57 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.1 t -91.43 -32.45 15.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.873 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.516 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.4 p -146.36 154.63 41.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.88 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.6 p -153.41 172.01 17.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 106.62 -142.06 15.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.44 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.3 t 56.99 86.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.836 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.91 157.52 43.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.77 -100.71 0.18 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.499 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 103.8 101.39 2.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.488 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -119.94 -44.49 2.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.953 0.406 . . . . 0.0 110.908 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -107.35 155.03 40.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.571 0.701 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -24.06 30.06 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.642 2.228 . . . . 0.0 112.394 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -87.14 100.26 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -135.05 111.36 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -67.25 130.37 42.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.49 -9.29 41.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -76.6 -37.7 56.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.17 -32.8 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.41 50.45 2.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.458 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.58 -178.99 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.49 139.52 35.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -130.01 149.91 51.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 98.1 p -81.41 -29.57 33.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.19 164.49 18.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -76.55 -53.74 7.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.64 -45.68 23.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.493 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.3 m -51.5 -38.74 55.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.942 0.401 . . . . 0.0 110.887 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 15.0 tp -72.23 -32.83 67.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 18.3 mt -60.34 -30.63 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.8 t -81.39 -10.84 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -93.63 -32.85 13.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.6 mt -56.66 -21.57 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -54.93 -26.0 33.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.7 m -82.45 -26.56 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -96.51 -74.82 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.12 150.97 23.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.65 103.27 0.1 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.452 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.42 25.19 7.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.96 0.41 . . . . 0.0 110.845 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -175.85 166.17 37.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.446 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -173.4 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.696 2.264 . . . . 0.0 112.337 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 59.9 m 53.92 28.03 8.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.5 m -54.32 148.0 12.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.494 -179.993 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 4.5 m 61.41 -170.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.357 . . . . 0.0 110.884 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 7.7 t -169.77 -59.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 102.61 140.93 11.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.4 t -159.23 -179.09 7.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.35 160.09 32.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -155.0 -110.89 0.38 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.508 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.0 26.6 69.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.439 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -82.55 -62.8 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.926 0.393 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -96.02 154.6 38.87 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.518 0.675 . . . . 0.0 110.901 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -23.55 30.64 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.708 2.272 . . . . 0.0 112.309 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -87.72 100.34 12.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.79 111.45 9.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -67.54 129.89 41.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.46 -9.24 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -76.23 -36.87 58.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.04 -32.84 4.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.85 50.53 1.93 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -178.83 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.333 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.06 140.04 34.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.067 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -129.99 150.16 51.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.83 -29.59 35.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -123.26 165.37 17.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -52.78 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.31 -45.57 28.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.52 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.69 -38.84 56.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.862 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 12.4 tp -71.5 -32.56 68.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.93 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.0 mt -60.45 -32.27 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.3 t -80.2 -10.7 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -92.93 -33.87 14.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 55.0 mt -58.23 -20.49 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -55.27 -25.42 33.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 11.5 m -85.24 -24.89 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.121 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -93.86 -74.71 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.12 150.94 23.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.139 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.64 102.85 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.504 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.67 -26.27 7.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 0.0 110.857 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -157.56 -75.54 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.47 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 88.38 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.688 2.258 . . . . 0.0 112.389 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.49 152.57 45.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.859 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.1 t 57.9 -173.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 CA-C-O 119.153 -0.804 . . . . 0.0 112.504 -179.976 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.13 -49.42 6.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.902 0.382 . . . . 0.0 110.905 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.34 92.27 3.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -154.52 -58.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.47 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 m 54.25 77.55 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.8 p -129.96 135.48 48.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 112.04 -110.29 2.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.47 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -163.16 110.52 0.43 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.487 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -99.36 131.3 45.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.903 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.79 153.73 55.27 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.592 0.71 . . . . 0.0 110.93 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -15.99 37.16 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.677 2.251 . . . . 0.0 112.32 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -95.52 99.73 11.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -135.09 111.64 9.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -66.94 131.19 45.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -92.45 -13.2 30.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -72.21 -36.47 69.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.7 p -120.21 -32.76 4.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 94.54 50.81 2.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.472 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -114.12 -179.24 3.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.771 0.32 . . . . 0.0 110.926 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -138.79 137.77 36.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -127.87 144.85 51.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.8 t -75.83 -31.28 59.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -123.12 164.87 17.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -76.25 -52.59 9.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.2 -45.17 27.48 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.499 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -39.49 58.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.848 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 13.9 tp -71.1 -33.79 70.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.7 mt -58.89 -31.92 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.98 -10.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.169 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.0 t60 -93.42 -31.9 14.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.885 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 58.2 mt -56.34 -21.98 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -55.51 -25.64 38.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.0 m -81.98 -25.62 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -98.69 -74.95 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.846 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.54 150.99 22.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.87 103.16 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.457 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.4 t -129.32 161.86 29.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.39 . . . . 0.0 110.809 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 109.82 -175.16 18.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.48 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -28.37 25.2 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.66 2.24 . . . . 0.0 112.357 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 63.6 p -151.26 136.45 17.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.831 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.22 171.69 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.823 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.461 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.8 t -105.38 125.44 50.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.836 0.35 . . . . 0.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 55.2 p -86.37 -178.04 6.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.839 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -171.53 84.73 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.467 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.18 164.93 25.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 74.7 m -97.06 159.76 14.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -131.55 -125.46 2.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -107.68 159.78 14.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.511 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.29 119.95 19.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.371 . . . . 0.0 110.92 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.64 153.68 37.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.615 0.721 . . . . 0.0 110.856 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -15.63 37.06 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.658 2.239 . . . . 0.0 112.367 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -96.65 99.6 11.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.79 111.59 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.87 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.7 t -67.44 131.08 44.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -92.42 -12.64 31.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -72.78 -36.86 67.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.8 p -119.93 -32.57 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.854 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 94.52 50.88 2.09 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -114.09 -179.27 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.04 136.44 33.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -126.52 146.97 49.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.59 -30.64 52.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.59 165.36 16.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -52.92 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.21 -45.38 27.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.467 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.55 -39.55 57.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.902 0.382 . . . . 0.0 110.82 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.99 -33.16 70.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.5 mt -59.6 -32.37 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.0 t -80.38 -10.73 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -93.26 -32.16 14.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 58.6 mt -56.58 -21.78 13.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -55.5 -25.71 38.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.5 m -82.3 -25.03 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.132 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -98.95 -75.07 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 m -101.37 151.01 22.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.54 103.12 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.558 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.8 t -130.74 26.53 5.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.955 0.407 . . . . 0.0 110.863 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -156.72 -74.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 141.4 45.26 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.691 2.26 . . . . 0.0 112.389 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.1 -31.37 65.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.5 t -123.78 149.74 45.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 CA-C-O 119.181 -0.788 . . . . 0.0 112.476 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.5 m -144.63 147.36 33.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.891 0.376 . . . . 0.0 110.877 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.55 94.04 3.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.823 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -137.29 38.67 1.71 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.481 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.62 133.25 52.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 0.0 110.881 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.35 -58.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 73.93 41.83 39.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.517 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.18 -24.13 52.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.455 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -55.82 -71.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.964 0.411 . . . . 0.0 110.94 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -115.13 155.72 46.33 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.562 0.696 . . . . 0.0 110.938 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.77 -24.82 29.2 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.675 2.25 . . . . 0.0 112.309 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -85.73 100.62 12.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -136.12 111.43 9.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 10.1 t -67.76 130.35 42.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.34 -10.16 39.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -75.28 -36.67 61.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.33 -33.1 3.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.54 48.42 2.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -111.34 -178.8 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.788 0.328 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.71 139.11 32.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -130.14 152.65 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 27.4 t -83.77 -29.04 27.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -123.41 163.86 20.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.3 -52.66 9.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.11 -46.23 27.0 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 m -51.66 -38.62 55.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.6 tp -71.43 -32.17 68.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.7 mt -60.95 -33.03 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.11 -10.8 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -93.32 -36.48 12.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.75 -19.92 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -23.92 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 11.5 m -87.75 -23.8 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -91.14 -74.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.1 m -104.55 151.2 23.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.0 103.07 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.25 -62.87 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.818 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -101.68 168.26 19.35 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.452 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -22.19 32.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.638 2.225 . . . . 0.0 112.325 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 24.2 p -108.61 137.67 46.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 73.1 m 58.45 94.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.459 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.1 92.85 4.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 110.879 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 78.0 p -152.28 149.6 28.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.856 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -68.26 -132.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.459 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.65 135.14 14.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.916 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.8 p -84.33 -55.58 4.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 153.57 -66.45 0.32 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.506 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.9 109.4 0.48 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.55 -34.19 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.376 . . . . 0.0 110.869 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.6 156.54 47.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.578 0.704 . . . . 0.0 110.922 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -26.09 28.13 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.706 2.27 . . . . 0.0 112.339 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -85.14 104.21 14.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.877 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 108.75 5.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -65.34 130.7 44.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.51 -9.74 40.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -76.37 -36.91 57.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.17 -32.89 4.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.4 39.31 3.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.518 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.28 -179.99 4.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 0.0 110.872 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.18 138.46 28.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -133.21 163.96 28.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.7 m -101.9 -21.77 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.855 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -123.58 138.94 54.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -56.53 20.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.68 -45.13 24.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.504 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.41 -39.79 58.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.888 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.3 tp -71.38 -32.4 68.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 17.3 mt -60.89 -31.77 50.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.137 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.9 t -78.33 -10.97 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -94.55 -31.32 13.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 56.5 mt -56.71 -21.59 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.1 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -55.48 -25.82 39.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.2 m -82.17 -25.14 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -98.59 -74.92 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.2 m -104.71 151.07 24.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.27 103.2 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.484 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.0 t -123.15 46.95 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 110.898 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -170.79 67.28 0.15 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.509 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 165.23 31.66 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.68 2.253 . . . . 0.0 112.311 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.1 m 61.89 166.79 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.9 t 61.78 167.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 CA-C-O 119.125 -0.82 . . . . 0.0 112.504 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 50.7 m -96.62 55.55 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 110.873 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.0 t -52.38 -37.02 55.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.898 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 73.37 101.81 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.53 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.6 p -70.89 142.59 51.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 110.894 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 64.7 p -176.46 -177.61 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 128.84 137.31 4.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.53 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.34 -150.71 2.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -131.24 24.06 4.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -115.87 155.72 47.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.589 0.709 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -28.31 25.33 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.71 2.273 . . . . 0.0 112.305 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -82.8 104.58 13.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.36 109.13 5.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.0 130.42 43.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.4 -9.46 41.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -76.6 -36.88 57.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.19 -32.87 4.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.27 40.65 3.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.517 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -101.31 -179.71 4.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.19 139.21 28.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.098 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -133.43 164.44 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.2 m -102.45 -21.65 14.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -123.6 139.57 53.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.94 -56.93 15.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.71 -44.82 23.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.443 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.5 m -51.44 -40.23 58.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.905 0.384 . . . . 0.0 110.825 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.0 tp -71.05 -32.62 69.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.9 mt -60.67 -31.8 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.29 -10.98 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.148 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -94.54 -31.38 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 56.6 mt -57.17 -21.34 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.12 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -55.52 -26.03 40.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.3 m -82.34 -24.53 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.155 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -98.43 -74.71 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.47 151.2 25.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -50.86 103.2 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.509 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 17.7 t -117.02 68.45 0.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.909 0.385 . . . . 0.0 110.811 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 151.79 168.03 15.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.454 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 84.17 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 6.8 p -53.88 -32.49 53.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.02 46.06 27.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.848 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 CA-C-O 119.153 -0.804 . . . . 0.0 112.461 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 28.9 t -80.53 80.59 6.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 110.865 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 22.8 t -138.62 101.67 4.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 172.28 38.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.457 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t -80.4 93.12 5.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.917 0.389 . . . . 0.0 110.894 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.0 m -150.11 152.96 35.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.844 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 52.18 85.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -153.77 117.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.465 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -175.13 -36.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.368 . . . . 0.0 110.877 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.32 155.35 92.64 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.62 0.724 . . . . 0.0 110.879 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -27.24 26.97 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.698 2.265 . . . . 0.0 112.38 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -84.13 105.04 14.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -142.53 106.56 4.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.885 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -63.43 129.39 40.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -91.08 -9.4 45.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.56 -37.01 57.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.11 -32.86 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.21 38.81 3.93 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.489 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -98.29 -179.73 4.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 0.0 110.903 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -143.86 138.8 28.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.082 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -133.93 164.15 27.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 5.1 m -102.44 -21.36 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -124.22 141.29 52.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -56.91 16.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.52 -44.96 22.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.519 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.47 -39.95 58.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 110.83 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.5 tp -71.41 -32.27 68.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 17.9 mt -61.15 -31.64 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.8 t -78.54 -10.96 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.075 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -94.19 -31.2 14.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -57.15 -21.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.092 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.7 mtt-85 -55.47 -25.92 39.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.829 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.0 m -82.35 -25.13 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.131 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -97.56 -74.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.03 151.19 26.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.14 103.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.9 t -118.92 144.63 46.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 0.0 110.903 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 166.18 -174.93 41.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.438 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 146.97 62.09 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.702 2.268 . . . . 0.0 112.343 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 11.3 m 63.03 -177.63 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 88.9 p -104.93 57.96 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 CA-C-O 119.157 -0.802 . . . . 0.0 112.479 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.5 t -171.08 93.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 0.0 110.844 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.67 168.53 13.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -168.01 77.28 0.11 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 42.1 p -117.5 156.36 28.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.845 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.3 t -153.21 157.34 40.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 111.99 170.14 18.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.498 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 128.62 57.4 0.11 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.466 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.12 -28.88 13.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 0.0 110.856 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.73 156.24 35.48 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.595 0.712 . . . . 0.0 110.89 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -25.15 29.01 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.705 2.27 . . . . 0.0 112.326 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -86.27 103.82 15.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -141.68 107.19 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 12.3 t -64.9 129.06 38.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.924 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.33 -11.93 39.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -73.0 -37.36 67.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -120.24 -32.93 4.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.6 38.56 3.9 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -98.06 -179.97 4.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.8 137.73 26.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.056 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -133.04 164.06 27.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.98 -21.67 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -123.07 138.81 54.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -56.97 15.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.43 -45.65 22.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.45 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.63 -38.09 53.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 110.842 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 14.0 tp -73.24 -31.02 63.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 18.7 mt -62.88 -30.27 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.0 t -80.03 -10.85 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -93.46 -33.24 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 55.4 mt -59.39 -19.79 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -55.45 -25.0 33.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 12.8 m -86.13 -24.54 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -92.33 -75.05 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.98 151.01 22.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.147 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.66 102.99 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.47 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.41 102.19 9.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.927 0.394 . . . . 0.0 110.866 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 62.0 166.82 0.52 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.481 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 172.81 11.93 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.318 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 49.4 m -154.29 151.58 29.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 50.7 m -73.71 -49.63 24.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 119.182 -0.788 . . . . 0.0 112.524 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 67.1 p -166.15 -179.44 5.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.885 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.7 t -135.93 91.51 2.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.797 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -147.73 161.67 28.58 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.473 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 62.1 m -68.47 -26.31 65.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.902 0.382 . . . . 0.0 110.871 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 m 63.16 92.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.86 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.63 -150.7 19.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.5 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 140.98 132.93 2.88 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.454 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.1 53.7 1.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.946 0.403 . . . . 0.0 110.882 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -106.45 156.5 36.91 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.549 0.69 . . . . 0.0 110.859 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -26.19 27.56 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.674 2.249 . . . . 0.0 112.349 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -83.59 101.74 11.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -136.87 111.26 8.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.93 126.09 28.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -88.34 -10.93 47.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -73.01 -38.81 66.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.77 -33.15 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.5 48.1 2.05 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -111.66 -178.64 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.2 140.53 34.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -131.77 153.6 49.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.9 m -87.33 -27.09 23.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -123.58 157.05 34.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -54.68 10.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.97 -45.58 26.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.497 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.5 m -51.98 -36.29 49.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.839 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 13.2 tp -74.86 -31.75 61.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.7 mt -62.65 -27.6 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.26 -10.73 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.09 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -93.9 -36.8 12.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.58 -19.87 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.154 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -59.42 -20.7 57.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.9 m -98.02 8.11 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -114.8 -75.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.85 90.71 3.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 51.29 -106.98 0.34 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.485 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.76 88.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.38 . . . . 0.0 110.844 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.09 75.58 1.31 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 125.73 12.48 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.655 2.237 . . . . 0.0 112.36 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 74.5 p -123.76 164.26 19.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.83 36.38 4.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.859 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 119.106 -0.83 . . . . 0.0 112.499 -179.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.16 -26.98 14.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.914 0.388 . . . . 0.0 110.887 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m 62.93 -177.57 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.878 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 103.06 47.77 1.31 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.463 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.46 149.83 23.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.925 0.393 . . . . 0.0 110.794 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 82.1 p -103.94 74.54 1.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.853 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -102.42 -95.81 2.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.504 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 55.11 68.79 1.5 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.491 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -102.11 -26.52 13.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.391 . . . . 0.0 110.884 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.25 155.72 74.34 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.571 0.7 . . . . 0.0 110.872 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -26.7 27.57 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.738 2.292 . . . . 0.0 112.367 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -84.74 106.36 16.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -142.94 107.0 4.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.4 t -64.53 130.15 42.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.858 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -92.04 -9.52 42.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.847 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -76.44 -36.88 57.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.946 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.32 -32.85 4.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.01 39.83 3.7 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.481 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -100.31 -179.82 4.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.1 140.08 29.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.085 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -134.08 163.87 28.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 71.0 m -100.68 -22.42 14.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.819 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -123.43 144.26 49.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -61.46 -57.29 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -46.94 -44.31 18.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.463 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.5 m -51.63 -40.01 59.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 110.872 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 10.5 tp -72.0 -32.86 67.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 17.9 mt -60.99 -29.43 45.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 19.9 t -81.53 -10.81 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -94.35 -33.66 13.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.9 mt -57.92 -20.61 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -55.33 -25.26 33.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 11.4 m -84.5 -25.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -93.09 -74.71 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.24 151.03 24.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.4 102.9 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.47 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.97 -26.1 7.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 110.84 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -161.84 165.7 35.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -171.15 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.685 2.256 . . . . 0.0 112.332 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 16.5 p -97.95 87.5 4.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.9 p -87.43 -63.07 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.903 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 119.124 -0.82 . . . . 0.0 112.476 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.4 m -120.07 94.88 4.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 0.0 110.855 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.55 -170.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.842 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 147.57 141.38 3.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.8 p -146.57 177.58 8.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.89 0.376 . . . . 0.0 110.87 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.2 p -170.38 152.06 3.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.892 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.37 30.57 8.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.541 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 178.36 119.72 0.62 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.475 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -138.35 137.57 37.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 110.899 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -66.13 155.37 87.63 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.524 0.678 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -25.16 28.79 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.672 2.248 . . . . 0.0 112.349 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -85.81 99.95 11.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -135.09 111.57 9.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.2 t -68.71 128.04 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.57 -12.43 39.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.81 -38.55 70.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -118.82 -32.94 4.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.08 50.35 1.93 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.86 -178.56 3.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.792 0.329 . . . . 0.0 110.928 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.7 139.18 34.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.073 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -129.48 150.71 50.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 56.0 p -82.89 -28.78 29.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.65 162.41 23.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -53.85 8.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.7 -46.07 24.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.482 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.36 -37.58 48.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.901 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.7 -31.7 63.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.928 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 18.9 mt -61.93 -29.11 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 19.8 t -83.43 -10.88 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -95.09 -40.32 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 53.1 mt -57.79 -20.46 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -59.26 -21.19 59.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.4 m -97.46 7.45 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -113.25 -74.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 50.4 m -119.18 90.86 3.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 51.85 -107.19 0.42 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.494 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.75 88.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.938 0.399 . . . . 0.0 110.85 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 90.49 173.07 44.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.471 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 138.45 37.89 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.714 2.276 . . . . 0.0 112.387 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 70.4 m -101.75 90.71 4.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.4 m -116.4 -57.76 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.829 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 119.159 -0.801 . . . . 0.0 112.507 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 47.0 m -88.87 -45.13 9.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.936 0.398 . . . . 0.0 110.884 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.4 t -126.42 -45.52 1.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.841 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 142.95 66.09 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.503 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 61.8 p -145.91 176.52 9.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 110.85 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.2 m -115.17 -32.73 5.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.831 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -86.42 -134.03 3.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.461 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -137.29 162.92 25.41 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.463 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -53.74 -62.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 110.889 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -115.85 154.56 48.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.587 0.708 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -26.86 27.04 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.708 2.272 . . . . 0.0 112.33 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.19 110.53 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -144.94 104.38 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -62.9 127.25 30.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.58 -9.25 50.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -76.35 -37.26 57.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.36 -32.98 3.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.37 41.55 3.41 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -102.19 -179.35 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.341 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -143.11 142.28 31.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -135.86 162.5 32.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.0 -23.19 16.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -125.82 150.9 47.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.941 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -54.34 24.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.95 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.7 -46.26 24.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.447 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -51.29 -39.54 57.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 110.907 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.6 tp -70.86 -32.03 68.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.951 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 17.0 mt -61.45 -31.94 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.091 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.0 t -78.95 -10.84 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -93.73 -31.89 14.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 57.1 mt -56.7 -21.61 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -54.87 -26.22 34.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.8 m -81.49 -27.12 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.116 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -96.39 -74.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.86 150.98 22.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.78 103.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.16 25.23 5.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.95 0.405 . . . . 0.0 110.866 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -174.31 -69.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.491 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 126.81 13.74 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.642 2.228 . . . . 0.0 112.392 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.28 -50.52 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.822 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 78.1 p -127.94 166.07 19.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 CA-C-O 119.12 -0.822 . . . . 0.0 112.5 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.98 98.42 3.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.86 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.9 p -133.8 125.43 28.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -149.83 -77.38 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.499 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.8 161.0 40.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.2 t -106.86 -56.42 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.849 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.91 147.65 6.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.61 142.16 41.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.449 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -55.99 -26.91 50.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -100.73 156.43 35.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.65 0.738 . . . . 0.0 110.885 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -27.13 26.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.671 2.248 . . . . 0.0 112.361 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -82.45 101.61 10.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -136.69 111.26 8.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 16.0 t -69.12 124.51 23.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.71 -11.16 52.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.41 -40.07 67.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.974 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -117.81 -33.2 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.81 48.12 1.99 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.518 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -111.63 -178.73 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.71 140.98 34.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.13 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -132.24 153.22 50.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.3 p -86.5 -27.6 23.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.854 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -123.91 159.66 29.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -72.89 -54.5 8.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.8 -45.96 24.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.466 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.8 m -51.8 -36.24 47.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.917 0.389 . . . . 0.0 110.85 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 14.0 tp -74.92 -32.28 61.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.2 mt -62.36 -26.94 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 19.6 t -84.74 -10.8 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -94.35 -36.74 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.28 -20.03 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -59.32 -20.6 55.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.8 m -98.38 10.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.127 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -117.11 -75.07 0.58 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.22 90.82 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 51.06 -108.51 0.56 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.507 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.09 26.08 7.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.851 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 179.32 -75.73 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.497 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 178.35 4.61 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.727 2.284 . . . . 0.0 112.369 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.07 143.24 27.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 17.3 p -81.05 -44.56 17.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 CA-C-O 119.144 -0.809 . . . . 0.0 112.453 179.999 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? . . . . . 0 C--O 1.231 0.081 0 CA-C-O 121.58 0.705 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -25.27 28.99 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 0.0 112.365 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -84.96 101.12 12.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.954 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 31.7 ttp85 -137.83 111.16 7.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -66.7 129.49 40.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -91.78 -9.32 44.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -76.38 -36.96 57.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.15 -32.76 4.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.96 46.63 2.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -108.54 -179.38 3.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.32 141.4 33.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.066 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.581 ' CE1' HD13 ' A' ' 211' ' ' LEU . 15.2 m-85 -134.13 153.51 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.15 -28.47 25.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -123.52 162.78 22.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -53.1 9.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.97 -46.3 26.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 m -51.63 -38.6 55.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.87 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.581 HD13 ' CE1' ' A' ' 205' ' ' PHE . 9.7 tp -71.42 -32.26 68.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.955 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.539 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.5 mt -60.95 -32.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.404 ' O ' HG12 ' A' ' 213' ' ' VAL . 20.6 t -77.9 -10.74 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.722 ' O ' HG22 ' A' ' 217' ' ' VAL . 12.7 t60 -94.05 -32.51 13.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 212' ' ' ILE . 55.4 mt -56.72 -21.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.184 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -55.09 -26.14 35.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.5 m -82.51 -26.07 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -95.96 -74.07 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.153 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.596 0.713 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -24.42 29.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.232 . . . . 0.0 112.367 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -86.49 100.71 12.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -136.48 111.39 8.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.5 t -67.43 129.93 41.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.52 -9.31 41.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.838 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -76.12 -36.68 58.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.06 -32.72 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.15 50.23 1.94 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.75 -179.01 3.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.11 140.21 34.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.604 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.5 m-85 -131.02 151.45 51.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.942 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.79 -29.25 29.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.823 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -123.19 164.91 17.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.17 -53.05 8.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.11 -45.73 26.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.49 -39.4 57.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.844 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.604 HD13 ' CE1' ' A' ' 205' ' ' PHE . 12.2 tp -71.03 -32.9 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.53 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.8 mt -60.03 -32.45 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.0 t -79.12 -10.88 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.717 ' O ' HG22 ' A' ' 217' ' ' VAL . 15.1 t60 -94.01 -32.88 13.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.862 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.53 HD12 ' HA ' ' A' ' 212' ' ' ILE . 58.0 mt -56.39 -21.76 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -55.21 -25.93 36.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.2 m -82.42 -25.6 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -97.66 -74.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.184 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.552 0.691 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -24.74 29.69 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 0.0 112.368 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -86.02 100.61 12.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -136.75 111.31 8.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.8 130.65 43.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -92.48 -10.22 38.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.865 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -75.64 -36.94 60.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.88 -32.9 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.17 47.84 2.34 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -110.09 -179.2 3.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.799 0.333 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.66 140.12 34.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.079 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.6 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.4 m-85 -131.84 151.68 51.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.4 -29.03 28.48 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.831 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -123.18 164.77 18.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -53.08 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.23 -45.55 27.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.537 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.63 -39.38 57.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.848 0.356 . . . . 0.0 110.835 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.6 HD13 ' CE1' ' A' ' 205' ' ' PHE . 11.5 tp -71.01 -32.91 69.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.549 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.7 mt -60.0 -32.62 50.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.2 t -78.83 -10.79 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.094 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.719 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.2 t60 -94.18 -32.35 13.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 212' ' ' ILE . 56.0 mt -56.45 -21.68 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -55.52 -25.73 39.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.1 m -82.5 -24.88 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -98.5 -74.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.105 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.543 0.687 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -24.58 29.39 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.685 2.257 . . . . 0.0 112.36 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -86.19 100.63 12.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -136.04 111.3 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.851 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -67.32 130.15 42.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -92.5 -9.26 42.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -76.43 -37.44 57.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.43 -32.77 4.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.04 49.81 2.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.91 -179.05 3.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 0.0 110.935 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.82 139.75 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.596 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.2 m-85 -130.61 151.43 51.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 83.7 p -83.1 -28.93 29.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.78 163.8 20.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.937 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -76.03 -53.12 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.84 -45.87 25.25 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.455 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.52 -39.11 57.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 0.0 110.808 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.596 HD13 ' CE1' ' A' ' 205' ' ' PHE . 12.3 tp -71.36 -33.34 69.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.7 mt -59.68 -32.08 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 20.7 t -79.78 -10.87 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.724 ' O ' HG22 ' A' ' 217' ' ' VAL . 15.4 t60 -94.04 -33.19 13.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 212' ' ' ILE . 55.8 mt -56.51 -21.69 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -55.36 -25.86 37.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.1 m -82.72 -25.09 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -97.53 -74.19 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.579 0.704 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -24.51 29.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 0.0 112.355 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -86.5 100.54 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.43 111.34 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.5 t -67.47 130.18 42.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -92.56 -9.91 39.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -75.51 -36.6 60.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.17 -32.76 4.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.04 50.11 1.97 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -113.59 -179.02 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.85 140.37 34.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.075 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.605 ' CE1' HD13 ' A' ' 211' ' ' LEU . 17.1 m-85 -131.07 151.42 51.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 38.7 t -83.05 -29.03 29.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -123.17 164.8 18.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -53.22 8.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.921 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.28 -45.32 28.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.49 -39.67 58.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.877 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.605 HD13 ' CE1' ' A' ' 205' ' ' PHE . 12.7 tp -70.89 -33.13 70.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.915 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.524 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.3 mt -59.7 -32.54 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.1 t -79.23 -10.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.718 ' O ' HG22 ' A' ' 217' ' ' VAL . 15.0 t60 -94.02 -32.64 13.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.856 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 212' ' ' ILE . 59.0 mt -56.41 -21.79 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -55.4 -25.79 37.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 214' ' ' HIS . 9.6 m -82.43 -25.08 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -98.48 -74.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.162 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.56 0.695 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -23.99 29.94 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.693 2.262 . . . . 0.0 112.339 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -86.91 103.59 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -138.05 110.59 7.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -66.5 130.38 42.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.48 -9.29 41.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.852 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -76.66 -37.39 56.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -119.66 -32.94 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.81 49.02 2.19 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.455 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -111.67 -178.97 3.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.36 141.18 35.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.09 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.591 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.7 m-85 -132.32 151.35 51.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.15 -28.98 29.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -123.31 163.72 20.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -53.16 8.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.29 -45.57 28.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.3 m -51.52 -39.24 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.862 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.591 HD13 ' CE1' ' A' ' 205' ' ' PHE . 11.3 tp -71.16 -33.07 69.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.958 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.1 mt -59.89 -32.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.089 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.1 t -79.35 -10.87 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.724 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.5 t60 -94.17 -32.33 13.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.832 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 212' ' ' ILE . 58.7 mt -56.8 -21.56 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.108 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -55.4 -25.72 37.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.3 m -82.77 -24.96 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.079 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -98.34 -75.0 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.571 0.701 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -24.06 30.06 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.642 2.228 . . . . 0.0 112.394 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -87.14 100.26 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -135.05 111.36 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -67.25 130.37 42.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.49 -9.29 41.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -76.6 -37.7 56.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.17 -32.8 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.41 50.45 2.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.458 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.58 -178.99 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.49 139.52 35.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.606 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.2 m-85 -130.01 149.91 51.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 98.1 p -81.41 -29.57 33.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.19 164.49 18.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -76.55 -53.74 7.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.64 -45.68 23.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.493 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.3 m -51.5 -38.74 55.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.942 0.401 . . . . 0.0 110.887 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.606 HD13 ' CE1' ' A' ' 205' ' ' PHE . 15.0 tp -72.23 -32.83 67.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.518 ' HA ' HD12 ' A' ' 215' ' ' ILE . 18.3 mt -60.34 -30.63 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.8 t -81.39 -10.84 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.718 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.5 t60 -93.63 -32.85 13.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 212' ' ' ILE . 54.6 mt -56.66 -21.57 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -54.93 -26.0 33.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.7 m -82.45 -26.56 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -96.51 -74.82 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.518 0.675 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -23.55 30.64 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.708 2.272 . . . . 0.0 112.309 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -87.72 100.34 12.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.79 111.45 9.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -67.54 129.89 41.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.46 -9.24 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -76.23 -36.87 58.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.04 -32.84 4.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.85 50.53 1.93 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -178.83 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.333 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.06 140.04 34.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.067 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.622 ' CE1' HD13 ' A' ' 211' ' ' LEU . 15.5 m-85 -129.99 150.16 51.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.83 -29.59 35.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -123.26 165.37 17.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -52.78 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.31 -45.57 28.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.52 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.69 -38.84 56.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.862 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.622 HD13 ' CE1' ' A' ' 205' ' ' PHE . 12.4 tp -71.5 -32.56 68.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.93 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.435 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.0 mt -60.45 -32.27 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.3 t -80.2 -10.7 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.744 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.7 t60 -92.93 -33.87 14.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 212' ' ' ILE . 55.0 mt -58.23 -20.49 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -55.27 -25.42 33.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 214' ' ' HIS . 11.5 m -85.24 -24.89 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.121 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -93.86 -74.71 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.139 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.592 0.71 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -15.99 37.16 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.677 2.251 . . . . 0.0 112.32 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -95.52 99.73 11.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -135.09 111.64 9.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -66.94 131.19 45.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -92.45 -13.2 30.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -72.21 -36.47 69.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.7 p -120.21 -32.76 4.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 94.54 50.81 2.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.472 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -114.12 -179.24 3.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.771 0.32 . . . . 0.0 110.926 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -138.79 137.77 36.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.618 ' CE1' HD13 ' A' ' 211' ' ' LEU . 18.4 m-85 -127.87 144.85 51.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.8 t -75.83 -31.28 59.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -123.12 164.87 17.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -76.25 -52.59 9.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.2 -45.17 27.48 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.499 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -39.49 58.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.848 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.618 HD13 ' CE1' ' A' ' 205' ' ' PHE . 13.9 tp -71.1 -33.79 70.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.503 ' HA ' HD12 ' A' ' 215' ' ' ILE . 15.7 mt -58.89 -31.92 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.6 t -80.98 -10.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.169 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.709 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.0 t60 -93.42 -31.9 14.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 212' ' ' ILE . 58.2 mt -56.34 -21.98 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -55.51 -25.64 38.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 214' ' ' HIS . 9.0 m -81.98 -25.62 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -98.69 -74.95 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.846 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.615 0.721 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -15.63 37.06 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.658 2.239 . . . . 0.0 112.367 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -96.65 99.6 11.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.79 111.59 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.87 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.7 t -67.44 131.08 44.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -92.42 -12.64 31.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -72.78 -36.86 67.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.8 p -119.93 -32.57 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.854 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 94.52 50.88 2.09 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -114.09 -179.27 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.04 136.44 33.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.604 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.3 m-85 -126.52 146.97 49.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.59 -30.64 52.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.59 165.36 16.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -52.92 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.21 -45.38 27.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.467 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.55 -39.55 57.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.902 0.382 . . . . 0.0 110.82 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.604 HD13 ' CE1' ' A' ' 205' ' ' PHE . 14.2 tp -70.99 -33.16 70.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.495 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.5 mt -59.6 -32.37 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 213' ' ' VAL . 21.0 t -80.38 -10.73 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.717 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.2 t60 -93.26 -32.16 14.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 212' ' ' ILE . 58.6 mt -56.58 -21.78 13.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -55.5 -25.71 38.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 214' ' ' HIS . 9.5 m -82.3 -25.03 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.132 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -98.95 -75.07 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.562 0.696 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.77 -24.82 29.2 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.675 2.25 . . . . 0.0 112.309 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -85.73 100.62 12.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -136.12 111.43 9.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 10.1 t -67.76 130.35 42.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.34 -10.16 39.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -75.28 -36.67 61.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.33 -33.1 3.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.54 48.42 2.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -111.34 -178.8 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.788 0.328 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.71 139.11 32.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.592 ' CE1' HD13 ' A' ' 211' ' ' LEU . 15.5 m-85 -130.14 152.65 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 27.4 t -83.77 -29.04 27.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -123.41 163.86 20.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.3 -52.66 9.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.11 -46.23 27.0 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 m -51.66 -38.62 55.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.592 HD13 ' CE1' ' A' ' 205' ' ' PHE . 11.6 tp -71.43 -32.17 68.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.7 mt -60.95 -33.03 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.3 t -79.11 -10.8 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.749 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.8 t60 -93.32 -36.48 12.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.75 -19.92 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -23.92 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 214' ' ' HIS . 11.5 m -87.75 -23.8 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -91.14 -74.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 -179.91 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.578 0.704 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -26.09 28.13 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.706 2.27 . . . . 0.0 112.339 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -85.14 104.21 14.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.877 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 108.75 5.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -65.34 130.7 44.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.51 -9.74 40.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -76.37 -36.91 57.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.17 -32.89 4.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.4 39.31 3.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.518 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.28 -179.99 4.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 0.0 110.872 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.18 138.46 28.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.55 ' CE1' HD13 ' A' ' 211' ' ' LEU . 10.5 m-85 -133.21 163.96 28.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.7 m -101.9 -21.77 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.855 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -123.58 138.94 54.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -56.53 20.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.68 -45.13 24.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.504 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.41 -39.79 58.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.888 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 211' ' ' LEU . 9.3 tp -71.38 -32.4 68.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.582 ' HA ' HD12 ' A' ' 215' ' ' ILE . 17.3 mt -60.89 -31.77 50.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.137 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 213' ' ' VAL . 20.9 t -78.33 -10.97 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.718 ' O ' HG22 ' A' ' 217' ' ' VAL . 11.7 t60 -94.55 -31.32 13.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 212' ' ' ILE . 56.5 mt -56.71 -21.59 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.1 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -55.48 -25.82 39.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.2 m -82.17 -25.14 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -98.59 -74.92 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 -179.942 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.589 0.709 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -28.31 25.33 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.71 2.273 . . . . 0.0 112.305 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -82.8 104.58 13.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.36 109.13 5.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.0 130.42 43.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.4 -9.46 41.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -76.6 -36.88 57.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.19 -32.87 4.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.27 40.65 3.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.517 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -101.31 -179.71 4.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.19 139.21 28.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.098 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.55 ' CE1' HD13 ' A' ' 211' ' ' LEU . 11.2 m-85 -133.43 164.44 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.2 m -102.45 -21.65 14.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -123.6 139.57 53.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.94 -56.93 15.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.71 -44.82 23.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.443 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.5 m -51.44 -40.23 58.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.905 0.384 . . . . 0.0 110.825 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 211' ' ' LEU . 9.0 tp -71.05 -32.62 69.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.572 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.9 mt -60.67 -31.8 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.2 t -78.29 -10.98 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.148 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.728 ' O ' HG22 ' A' ' 217' ' ' VAL . 11.6 t60 -94.54 -31.38 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 212' ' ' ILE . 56.6 mt -57.17 -21.34 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.12 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -55.52 -26.03 40.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.3 m -82.34 -24.53 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.155 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -98.43 -74.71 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.62 0.724 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -27.24 26.97 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.698 2.265 . . . . 0.0 112.38 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -84.13 105.04 14.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -142.53 106.56 4.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.885 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -63.43 129.39 40.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -91.08 -9.4 45.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.56 -37.01 57.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.11 -32.86 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.21 38.81 3.93 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.489 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -98.29 -179.73 4.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 0.0 110.903 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -143.86 138.8 28.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.082 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.538 ' CE1' HD13 ' A' ' 211' ' ' LEU . 12.6 m-85 -133.93 164.15 27.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 5.1 m -102.44 -21.36 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -124.22 141.29 52.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -56.91 16.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.52 -44.96 22.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.519 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.47 -39.95 58.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 110.83 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 211' ' ' LEU . 9.5 tp -71.41 -32.27 68.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.93 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.574 ' HA ' HD12 ' A' ' 215' ' ' ILE . 17.9 mt -61.15 -31.64 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.8 t -78.54 -10.96 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.075 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.722 ' O ' HG22 ' A' ' 217' ' ' VAL . 10.6 t60 -94.19 -31.2 14.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 212' ' ' ILE . 54.8 mt -57.15 -21.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.092 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.7 mtt-85 -55.47 -25.92 39.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.829 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.0 m -82.35 -25.13 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.131 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -97.56 -74.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.595 0.712 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -25.15 29.01 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.705 2.27 . . . . 0.0 112.326 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -86.27 103.82 15.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -141.68 107.19 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 12.3 t -64.9 129.06 38.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.924 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.33 -11.93 39.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -73.0 -37.36 67.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -120.24 -32.93 4.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.6 38.56 3.9 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -98.06 -179.97 4.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.8 137.73 26.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.056 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.575 ' CE1' HD13 ' A' ' 211' ' ' LEU . 9.8 m-85 -133.04 164.06 27.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.98 -21.67 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -123.07 138.81 54.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -56.97 15.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.43 -45.65 22.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.45 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.63 -38.09 53.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 110.842 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.575 HD13 ' CE1' ' A' ' 205' ' ' PHE . 14.0 tp -73.24 -31.02 63.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.435 ' HA ' HD12 ' A' ' 215' ' ' ILE . 18.7 mt -62.88 -30.27 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.0 t -80.03 -10.85 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.749 ' O ' HG22 ' A' ' 217' ' ' VAL . 9.6 t60 -93.46 -33.24 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 212' ' ' ILE . 55.4 mt -59.39 -19.79 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -55.45 -25.0 33.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 214' ' ' HIS . 12.8 m -86.13 -24.54 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -92.33 -75.05 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.147 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.549 0.69 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -26.19 27.56 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.674 2.249 . . . . 0.0 112.349 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -83.59 101.74 11.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -136.87 111.26 8.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.93 126.09 28.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -88.34 -10.93 47.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -73.01 -38.81 66.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.77 -33.15 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.5 48.1 2.05 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -111.66 -178.64 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.2 140.53 34.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.644 ' CE1' HD13 ' A' ' 211' ' ' LEU . 15.9 m-85 -131.77 153.6 49.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.9 m -87.33 -27.09 23.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -123.58 157.05 34.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -54.68 10.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.97 -45.58 26.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.497 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.5 m -51.98 -36.29 49.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.839 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.644 HD13 ' CE1' ' A' ' 205' ' ' PHE . 13.2 tp -74.86 -31.75 61.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.7 mt -62.65 -27.6 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.26 -10.73 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.09 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.761 ' O ' HG22 ' A' ' 217' ' ' VAL . 9.1 t60 -93.9 -36.8 12.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.58 -19.87 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.154 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -59.42 -20.7 57.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 214' ' ' HIS . 5.9 m -98.02 8.11 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -114.8 -75.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.571 0.7 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -26.7 27.57 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.738 2.292 . . . . 0.0 112.367 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -84.74 106.36 16.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -142.94 107.0 4.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.4 t -64.53 130.15 42.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.858 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -92.04 -9.52 42.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.847 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -76.44 -36.88 57.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.946 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.32 -32.85 4.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.01 39.83 3.7 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.481 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -100.31 -179.82 4.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.1 140.08 29.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.085 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.529 ' CE1' HD13 ' A' ' 211' ' ' LEU . 12.1 m-85 -134.08 163.87 28.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 71.0 m -100.68 -22.42 14.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.819 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -123.43 144.26 49.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.416 ' HD2' HD11 ' A' ' 212' ' ' ILE . 2.3 tmtm? -61.46 -57.29 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -46.94 -44.31 18.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.463 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.5 m -51.63 -40.01 59.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 110.872 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.529 HD13 ' CE1' ' A' ' 205' ' ' PHE . 10.5 tp -72.0 -32.86 67.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.475 ' HA ' HD12 ' A' ' 215' ' ' ILE . 17.9 mt -60.99 -29.43 45.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 213' ' ' VAL . 19.9 t -81.53 -10.81 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.74 ' O ' HG22 ' A' ' 217' ' ' VAL . 10.1 t60 -94.35 -33.66 13.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 212' ' ' ILE . 54.9 mt -57.92 -20.61 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -55.33 -25.26 33.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 214' ' ' HIS . 11.4 m -84.5 -25.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -93.09 -74.71 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.524 0.678 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -25.16 28.79 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.672 2.248 . . . . 0.0 112.349 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -85.81 99.95 11.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -135.09 111.57 9.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.2 t -68.71 128.04 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.57 -12.43 39.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.81 -38.55 70.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -118.82 -32.94 4.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.08 50.35 1.93 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.86 -178.56 3.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.792 0.329 . . . . 0.0 110.928 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.7 139.18 34.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.073 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.592 ' CE1' HD13 ' A' ' 211' ' ' LEU . 17.2 m-85 -129.48 150.71 50.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 56.0 p -82.89 -28.78 29.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.65 162.41 23.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -53.85 8.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.7 -46.07 24.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.482 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.36 -37.58 48.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.901 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.592 HD13 ' CE1' ' A' ' 205' ' ' PHE . 15.0 tp -73.7 -31.7 63.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.928 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 18.9 mt -61.93 -29.11 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 213' ' ' VAL . 19.8 t -83.43 -10.88 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.753 ' O ' HG22 ' A' ' 217' ' ' VAL . 10.0 t60 -95.09 -40.32 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 53.1 mt -57.79 -20.46 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -59.26 -21.19 59.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 214' ' ' HIS . 5.4 m -97.46 7.45 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -113.25 -74.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 50.4 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 -179.894 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.587 0.708 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -26.86 27.04 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.708 2.272 . . . . 0.0 112.33 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.19 110.53 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -144.94 104.38 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -62.9 127.25 30.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.58 -9.25 50.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -76.35 -37.26 57.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.36 -32.98 3.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.37 41.55 3.41 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -102.19 -179.35 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.341 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -143.11 142.28 31.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.476 ' CE1' HD13 ' A' ' 211' ' ' LEU . 14.7 m-85 -135.86 162.5 32.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.0 -23.19 16.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -125.82 150.9 47.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.941 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -54.34 24.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.95 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.7 -46.26 24.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.447 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -51.29 -39.54 57.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 110.907 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 211' ' ' LEU . 9.6 tp -70.86 -32.03 68.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.951 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.527 ' HA ' HD12 ' A' ' 215' ' ' ILE . 17.0 mt -61.45 -31.94 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.091 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.0 t -78.95 -10.84 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.71 ' O ' HG22 ' A' ' 217' ' ' VAL . 11.2 t60 -93.73 -31.89 14.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 212' ' ' ILE . 57.1 mt -56.7 -21.61 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.135 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -54.87 -26.22 34.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.8 m -81.49 -27.12 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.116 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -96.39 -74.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.65 0.738 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -27.13 26.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.671 2.248 . . . . 0.0 112.361 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -82.45 101.61 10.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -136.69 111.26 8.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 16.0 t -69.12 124.51 23.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.71 -11.16 52.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.41 -40.07 67.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.974 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -117.81 -33.2 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.81 48.12 1.99 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.518 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -111.63 -178.73 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.71 140.98 34.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.13 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.651 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.8 m-85 -132.24 153.22 50.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.3 p -86.5 -27.6 23.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.854 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -123.91 159.66 29.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -72.89 -54.5 8.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.8 -45.96 24.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.466 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.8 m -51.8 -36.24 47.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.917 0.389 . . . . 0.0 110.85 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.651 HD13 ' CE1' ' A' ' 205' ' ' PHE . 14.0 tp -74.92 -32.28 61.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.2 mt -62.36 -26.94 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 19.6 t -84.74 -10.8 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.76 ' O ' HG22 ' A' ' 217' ' ' VAL . 8.7 t60 -94.35 -36.74 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.28 -20.03 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -59.32 -20.6 55.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 214' ' ' HIS . 5.8 m -98.38 10.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.127 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -117.11 -75.07 0.58 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.36 97.03 1.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 110.898 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.35 178.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 66.51 88.03 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.464 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 51.0 m -157.37 64.72 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.865 0.364 . . . . 0.0 110.846 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.03 139.94 33.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -151.24 114.51 0.65 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 131.09 -46.34 1.08 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.505 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 52.11 54.99 9.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.916 0.389 . . . . 0.0 110.905 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -91.26 156.14 43.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.58 0.705 . . . . 0.0 110.931 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -25.27 28.99 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 0.0 112.365 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -84.96 101.12 12.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.954 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 31.7 ttp85 -137.83 111.16 7.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -66.7 129.49 40.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -91.78 -9.32 44.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -76.38 -36.96 57.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.15 -32.76 4.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.96 46.63 2.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -108.54 -179.38 3.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.32 141.4 33.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.066 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.581 ' CE1' HD13 ' A' ' 211' ' ' LEU . 15.2 m-85 -134.13 153.51 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.15 -28.47 25.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -123.52 162.78 22.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -53.1 9.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.97 -46.3 26.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 m -51.63 -38.6 55.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.87 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.581 HD13 ' CE1' ' A' ' 205' ' ' PHE . 9.7 tp -71.42 -32.26 68.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.955 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.539 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.5 mt -60.95 -32.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.404 ' O ' HG12 ' A' ' 213' ' ' VAL . 20.6 t -77.9 -10.74 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.722 ' O ' HG22 ' A' ' 217' ' ' VAL . 12.7 t60 -94.05 -32.51 13.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 212' ' ' ILE . 55.4 mt -56.72 -21.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.184 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -55.09 -26.14 35.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.5 m -82.51 -26.07 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -95.96 -74.07 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.12 151.0 24.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.153 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.79 103.11 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.61 126.61 50.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 110.842 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 52.11 -172.85 0.28 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.514 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 145.77 58.39 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.651 2.234 . . . . 0.0 112.369 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 3.1 p -157.59 34.7 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.81 -172.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 CA-C-O 119.132 -0.816 . . . . 0.0 112.501 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.74 113.43 10.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.906 0.384 . . . . 0.0 110.874 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.56 136.32 2.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.885 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -141.56 -130.9 2.6 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.503 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.29 -26.93 17.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.369 . . . . 0.0 110.915 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.1 m 52.27 41.81 30.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.81 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.51 -93.93 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.493 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -139.14 143.82 14.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.482 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -131.72 168.97 16.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.93 0.395 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -105.29 155.37 37.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.713 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -24.42 29.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.232 . . . . 0.0 112.367 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -86.49 100.71 12.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -136.48 111.39 8.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.5 t -67.43 129.93 41.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.52 -9.31 41.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.838 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -76.12 -36.68 58.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.06 -32.72 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.15 50.23 1.94 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.75 -179.01 3.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.11 140.21 34.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.604 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.5 m-85 -131.02 151.45 51.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.942 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.79 -29.25 29.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.823 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -123.19 164.91 17.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.17 -53.05 8.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.11 -45.73 26.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.49 -39.4 57.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.844 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.604 HD13 ' CE1' ' A' ' 205' ' ' PHE . 12.2 tp -71.03 -32.9 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.53 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.8 mt -60.03 -32.45 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.0 t -79.12 -10.88 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.717 ' O ' HG22 ' A' ' 217' ' ' VAL . 15.1 t60 -94.01 -32.88 13.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.862 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.53 HD12 ' HA ' ' A' ' 212' ' ' ILE . 58.0 mt -56.39 -21.76 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -55.21 -25.93 36.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.2 m -82.42 -25.6 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -97.66 -74.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.45 150.99 24.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.184 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.49 103.12 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.501 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.1 t -123.15 148.73 45.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.951 0.405 . . . . 0.0 110.8 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 73.52 172.97 25.76 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.444 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 96.76 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.733 2.289 . . . . 0.0 112.339 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 4.2 m -116.17 163.2 16.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.822 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 2.9 t -152.72 -42.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.843 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.469 -179.958 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.11 80.53 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.896 0.379 . . . . 0.0 110.901 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 67.3 m -123.02 161.76 23.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.839 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 176.35 -140.7 5.17 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.467 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 m 51.95 64.31 1.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 110.881 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.6 p -139.54 56.07 1.66 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.816 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 108.15 160.58 20.51 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.437 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 167.99 79.27 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.484 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.33 -26.85 9.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.861 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -84.08 155.64 63.89 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.552 0.691 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -24.74 29.69 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 0.0 112.368 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -86.02 100.61 12.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -136.75 111.31 8.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.8 130.65 43.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -92.48 -10.22 38.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.865 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -75.64 -36.94 60.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.88 -32.9 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.17 47.84 2.34 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -110.09 -179.2 3.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.799 0.333 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.66 140.12 34.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.079 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.6 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.4 m-85 -131.84 151.68 51.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.4 -29.03 28.48 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.831 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -123.18 164.77 18.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -53.08 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.23 -45.55 27.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.537 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.63 -39.38 57.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.848 0.356 . . . . 0.0 110.835 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.6 HD13 ' CE1' ' A' ' 205' ' ' PHE . 11.5 tp -71.01 -32.91 69.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.549 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.7 mt -60.0 -32.62 50.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.2 t -78.83 -10.79 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.094 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.719 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.2 t60 -94.18 -32.35 13.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 212' ' ' ILE . 56.0 mt -56.45 -21.68 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -55.52 -25.73 39.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.1 m -82.5 -24.88 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -98.5 -74.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.73 151.08 24.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.105 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.25 103.19 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 44.2 t -122.99 47.77 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.913 0.387 . . . . 0.0 110.869 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -92.98 -167.51 38.95 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -34.8 13.67 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.648 2.232 . . . . 0.0 112.357 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 60.2 m -156.56 -51.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.01 108.85 1.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.842 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.506 179.984 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.89 136.98 52.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 0.0 110.902 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 55.4 m -72.06 -50.56 27.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.872 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.81 142.76 5.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.535 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.9 t -69.04 147.77 51.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 0.0 110.871 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.6 m -112.82 49.08 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.85 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 85.34 175.46 50.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.494 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.63 70.76 1.0 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.477 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.11 112.37 23.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.956 0.408 . . . . 0.0 110.849 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -112.62 155.5 43.78 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.543 0.687 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -24.58 29.39 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.685 2.257 . . . . 0.0 112.36 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -86.19 100.63 12.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -136.04 111.3 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.851 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -67.32 130.15 42.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -92.5 -9.26 42.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -76.43 -37.44 57.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.43 -32.77 4.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.04 49.81 2.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.91 -179.05 3.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 0.0 110.935 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.82 139.75 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.596 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.2 m-85 -130.61 151.43 51.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 83.7 p -83.1 -28.93 29.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.78 163.8 20.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.937 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -76.03 -53.12 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.84 -45.87 25.25 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.455 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.52 -39.11 57.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 0.0 110.808 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.596 HD13 ' CE1' ' A' ' 205' ' ' PHE . 12.3 tp -71.36 -33.34 69.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.7 mt -59.68 -32.08 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 20.7 t -79.78 -10.87 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.724 ' O ' HG22 ' A' ' 217' ' ' VAL . 15.4 t60 -94.04 -33.19 13.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 212' ' ' ILE . 55.8 mt -56.51 -21.69 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -55.36 -25.86 37.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.1 m -82.72 -25.09 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -97.53 -74.19 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.0 151.11 26.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.05 103.16 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.9 t -118.82 -34.96 3.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 0.0 110.873 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -143.07 165.69 26.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 93.83 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.674 2.25 . . . . 0.0 112.349 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 45.9 m -133.96 27.47 3.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 3.5 m 52.11 34.84 15.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 CA-C-O 119.118 -0.823 . . . . 0.0 112.516 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.1 97.3 9.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.856 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.21 128.53 6.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.846 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 141.84 50.73 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.456 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.3 p -130.15 27.88 5.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 0.0 110.893 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.1 m -101.41 173.9 6.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.907 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -104.11 -78.25 1.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.481 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 112.23 41.98 1.02 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.489 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -102.15 -27.72 12.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.943 0.401 . . . . 0.0 110.882 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -75.79 154.8 85.2 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.579 0.704 . . . . 0.0 110.889 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -24.51 29.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 0.0 112.355 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -86.5 100.54 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.43 111.34 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.5 t -67.47 130.18 42.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -92.56 -9.91 39.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -75.51 -36.6 60.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.17 -32.76 4.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.04 50.11 1.97 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -113.59 -179.02 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.85 140.37 34.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.075 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.605 ' CE1' HD13 ' A' ' 211' ' ' LEU . 17.1 m-85 -131.07 151.42 51.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 38.7 t -83.05 -29.03 29.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -123.17 164.8 18.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -53.22 8.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.921 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.28 -45.32 28.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.49 -39.67 58.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.877 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.605 HD13 ' CE1' ' A' ' 205' ' ' PHE . 12.7 tp -70.89 -33.13 70.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.915 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.524 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.3 mt -59.7 -32.54 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.1 t -79.23 -10.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.718 ' O ' HG22 ' A' ' 217' ' ' VAL . 15.0 t60 -94.02 -32.64 13.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.856 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 212' ' ' ILE . 59.0 mt -56.41 -21.79 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -55.4 -25.79 37.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 214' ' ' HIS . 9.6 m -82.43 -25.08 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -98.48 -74.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.02 151.08 22.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.162 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.33 103.15 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.514 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.3 t -130.94 26.4 4.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.38 . . . . 0.0 110.833 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -111.28 165.76 12.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -48.26 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.64 2.227 . . . . 0.0 112.34 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.27 94.43 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.82 -47.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.834 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.092 -0.838 . . . . 0.0 112.504 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.0 m -80.91 127.56 32.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.3 p -164.7 -175.66 3.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.835 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -165.72 147.21 11.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 31.5 m -97.19 -67.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.878 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.5 m 57.56 72.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 170.89 83.99 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.491 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 157.46 98.57 0.15 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.468 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.29 -25.98 9.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.921 0.391 . . . . 0.0 110.898 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -81.73 155.39 70.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.56 0.695 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -23.99 29.94 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.693 2.262 . . . . 0.0 112.339 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -86.91 103.59 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -138.05 110.59 7.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -66.5 130.38 42.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.48 -9.29 41.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.852 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -76.66 -37.39 56.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -119.66 -32.94 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.81 49.02 2.19 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.455 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -111.67 -178.97 3.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.36 141.18 35.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.09 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.591 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.7 m-85 -132.32 151.35 51.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.15 -28.98 29.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -123.31 163.72 20.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -53.16 8.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.29 -45.57 28.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.3 m -51.52 -39.24 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.862 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.591 HD13 ' CE1' ' A' ' 205' ' ' PHE . 11.3 tp -71.16 -33.07 69.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.958 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.1 mt -59.89 -32.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.089 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.1 t -79.35 -10.87 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.724 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.5 t60 -94.17 -32.33 13.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.832 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 212' ' ' ILE . 58.7 mt -56.8 -21.56 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.108 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -55.4 -25.72 37.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.3 m -82.77 -24.96 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.079 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -98.34 -75.0 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.91 151.1 24.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.11 103.08 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.5 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.1 t -123.91 46.55 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.827 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 162.94 -75.64 0.18 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.478 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 97.49 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.674 2.25 . . . . 0.0 112.385 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 13.7 m -104.8 39.57 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.1 t -91.43 -32.45 15.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.873 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.516 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.4 p -146.36 154.63 41.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.88 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.6 p -153.41 172.01 17.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 106.62 -142.06 15.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.44 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.3 t 56.99 86.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.836 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.91 157.52 43.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.77 -100.71 0.18 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.499 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 103.8 101.39 2.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.488 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -119.94 -44.49 2.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.953 0.406 . . . . 0.0 110.908 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -107.35 155.03 40.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.571 0.701 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -24.06 30.06 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.642 2.228 . . . . 0.0 112.394 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -87.14 100.26 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -135.05 111.36 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -67.25 130.37 42.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.49 -9.29 41.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -76.6 -37.7 56.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.17 -32.8 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.41 50.45 2.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.458 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.58 -178.99 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.49 139.52 35.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.606 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.2 m-85 -130.01 149.91 51.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 98.1 p -81.41 -29.57 33.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.19 164.49 18.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -76.55 -53.74 7.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.64 -45.68 23.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.493 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.3 m -51.5 -38.74 55.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.942 0.401 . . . . 0.0 110.887 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.606 HD13 ' CE1' ' A' ' 205' ' ' PHE . 15.0 tp -72.23 -32.83 67.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.518 ' HA ' HD12 ' A' ' 215' ' ' ILE . 18.3 mt -60.34 -30.63 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.8 t -81.39 -10.84 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.718 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.5 t60 -93.63 -32.85 13.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 212' ' ' ILE . 54.6 mt -56.66 -21.57 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -54.93 -26.0 33.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.7 m -82.45 -26.56 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -96.51 -74.82 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.12 150.97 23.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.65 103.27 0.1 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.452 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.42 25.19 7.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.96 0.41 . . . . 0.0 110.845 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -175.85 166.17 37.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.446 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -173.4 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.696 2.264 . . . . 0.0 112.337 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 59.9 m 53.92 28.03 8.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.5 m -54.32 148.0 12.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.494 -179.993 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 4.5 m 61.41 -170.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.357 . . . . 0.0 110.884 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 7.7 t -169.77 -59.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 102.61 140.93 11.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.4 t -159.23 -179.09 7.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.35 160.09 32.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -155.0 -110.89 0.38 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.508 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.0 26.6 69.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.439 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -82.55 -62.8 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.926 0.393 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -96.02 154.6 38.87 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.518 0.675 . . . . 0.0 110.901 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -23.55 30.64 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.708 2.272 . . . . 0.0 112.309 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -87.72 100.34 12.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.79 111.45 9.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -67.54 129.89 41.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.46 -9.24 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -76.23 -36.87 58.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.04 -32.84 4.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.85 50.53 1.93 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -178.83 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.333 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.06 140.04 34.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.067 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.622 ' CE1' HD13 ' A' ' 211' ' ' LEU . 15.5 m-85 -129.99 150.16 51.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.83 -29.59 35.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -123.26 165.37 17.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -52.78 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.31 -45.57 28.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.52 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.69 -38.84 56.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.862 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.622 HD13 ' CE1' ' A' ' 205' ' ' PHE . 12.4 tp -71.5 -32.56 68.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.93 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.435 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.0 mt -60.45 -32.27 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.3 t -80.2 -10.7 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.744 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.7 t60 -92.93 -33.87 14.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 212' ' ' ILE . 55.0 mt -58.23 -20.49 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -55.27 -25.42 33.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 214' ' ' HIS . 11.5 m -85.24 -24.89 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.121 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -93.86 -74.71 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.12 150.94 23.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.139 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.64 102.85 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.504 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.67 -26.27 7.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 0.0 110.857 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -157.56 -75.54 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.47 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 88.38 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.688 2.258 . . . . 0.0 112.389 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.49 152.57 45.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.859 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.1 t 57.9 -173.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 CA-C-O 119.153 -0.804 . . . . 0.0 112.504 -179.976 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.13 -49.42 6.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.902 0.382 . . . . 0.0 110.905 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.34 92.27 3.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -154.52 -58.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.47 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 m 54.25 77.55 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.8 p -129.96 135.48 48.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 112.04 -110.29 2.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.47 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -163.16 110.52 0.43 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.487 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -99.36 131.3 45.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.903 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.79 153.73 55.27 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.592 0.71 . . . . 0.0 110.93 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -15.99 37.16 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.677 2.251 . . . . 0.0 112.32 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -95.52 99.73 11.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -135.09 111.64 9.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -66.94 131.19 45.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -92.45 -13.2 30.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -72.21 -36.47 69.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.7 p -120.21 -32.76 4.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 94.54 50.81 2.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.472 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -114.12 -179.24 3.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.771 0.32 . . . . 0.0 110.926 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -138.79 137.77 36.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.618 ' CE1' HD13 ' A' ' 211' ' ' LEU . 18.4 m-85 -127.87 144.85 51.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.8 t -75.83 -31.28 59.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -123.12 164.87 17.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -76.25 -52.59 9.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.2 -45.17 27.48 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.499 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -39.49 58.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.848 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.618 HD13 ' CE1' ' A' ' 205' ' ' PHE . 13.9 tp -71.1 -33.79 70.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.503 ' HA ' HD12 ' A' ' 215' ' ' ILE . 15.7 mt -58.89 -31.92 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.6 t -80.98 -10.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.169 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.709 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.0 t60 -93.42 -31.9 14.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 212' ' ' ILE . 58.2 mt -56.34 -21.98 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -55.51 -25.64 38.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 214' ' ' HIS . 9.0 m -81.98 -25.62 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -98.69 -74.95 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.846 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.54 150.99 22.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.87 103.16 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.457 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.4 t -129.32 161.86 29.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.39 . . . . 0.0 110.809 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 109.82 -175.16 18.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.48 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -28.37 25.2 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.66 2.24 . . . . 0.0 112.357 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 63.6 p -151.26 136.45 17.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.831 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.22 171.69 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.823 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.461 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.8 t -105.38 125.44 50.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.836 0.35 . . . . 0.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 55.2 p -86.37 -178.04 6.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.839 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -171.53 84.73 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.467 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.18 164.93 25.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 74.7 m -97.06 159.76 14.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -131.55 -125.46 2.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -107.68 159.78 14.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.511 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.29 119.95 19.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.371 . . . . 0.0 110.92 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.64 153.68 37.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.615 0.721 . . . . 0.0 110.856 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -15.63 37.06 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.658 2.239 . . . . 0.0 112.367 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -96.65 99.6 11.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.79 111.59 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.87 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.7 t -67.44 131.08 44.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -92.42 -12.64 31.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -72.78 -36.86 67.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.8 p -119.93 -32.57 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.854 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 94.52 50.88 2.09 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -114.09 -179.27 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.04 136.44 33.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.604 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.3 m-85 -126.52 146.97 49.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.59 -30.64 52.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.59 165.36 16.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -52.92 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.21 -45.38 27.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.467 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.55 -39.55 57.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.902 0.382 . . . . 0.0 110.82 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.604 HD13 ' CE1' ' A' ' 205' ' ' PHE . 14.2 tp -70.99 -33.16 70.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.495 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.5 mt -59.6 -32.37 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 213' ' ' VAL . 21.0 t -80.38 -10.73 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.717 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.2 t60 -93.26 -32.16 14.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 212' ' ' ILE . 58.6 mt -56.58 -21.78 13.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -55.5 -25.71 38.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 214' ' ' HIS . 9.5 m -82.3 -25.03 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.132 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -98.95 -75.07 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 m -101.37 151.01 22.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.54 103.12 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.558 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.8 t -130.74 26.53 5.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.955 0.407 . . . . 0.0 110.863 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -156.72 -74.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 141.4 45.26 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.691 2.26 . . . . 0.0 112.389 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.1 -31.37 65.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.5 t -123.78 149.74 45.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 CA-C-O 119.181 -0.788 . . . . 0.0 112.476 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.5 m -144.63 147.36 33.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.891 0.376 . . . . 0.0 110.877 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.55 94.04 3.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.823 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -137.29 38.67 1.71 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.481 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.62 133.25 52.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 0.0 110.881 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.35 -58.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 73.93 41.83 39.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.517 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.18 -24.13 52.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.455 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -55.82 -71.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.964 0.411 . . . . 0.0 110.94 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -115.13 155.72 46.33 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.562 0.696 . . . . 0.0 110.938 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.77 -24.82 29.2 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.675 2.25 . . . . 0.0 112.309 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -85.73 100.62 12.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -136.12 111.43 9.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 10.1 t -67.76 130.35 42.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.34 -10.16 39.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -75.28 -36.67 61.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.33 -33.1 3.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.54 48.42 2.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -111.34 -178.8 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.788 0.328 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.71 139.11 32.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.592 ' CE1' HD13 ' A' ' 211' ' ' LEU . 15.5 m-85 -130.14 152.65 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 27.4 t -83.77 -29.04 27.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -123.41 163.86 20.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.3 -52.66 9.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.11 -46.23 27.0 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 m -51.66 -38.62 55.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.592 HD13 ' CE1' ' A' ' 205' ' ' PHE . 11.6 tp -71.43 -32.17 68.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.7 mt -60.95 -33.03 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.3 t -79.11 -10.8 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.749 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.8 t60 -93.32 -36.48 12.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.75 -19.92 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -23.92 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 214' ' ' HIS . 11.5 m -87.75 -23.8 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -91.14 -74.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.1 m -104.55 151.2 23.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.0 103.07 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.25 -62.87 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.818 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -101.68 168.26 19.35 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.452 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -22.19 32.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.638 2.225 . . . . 0.0 112.325 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 24.2 p -108.61 137.67 46.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 73.1 m 58.45 94.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.459 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.1 92.85 4.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 110.879 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 78.0 p -152.28 149.6 28.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.856 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -68.26 -132.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.459 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.65 135.14 14.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.916 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.8 p -84.33 -55.58 4.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 153.57 -66.45 0.32 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.506 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.9 109.4 0.48 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.55 -34.19 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.376 . . . . 0.0 110.869 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.6 156.54 47.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.578 0.704 . . . . 0.0 110.922 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -26.09 28.13 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.706 2.27 . . . . 0.0 112.339 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -85.14 104.21 14.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.877 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 108.75 5.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -65.34 130.7 44.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.51 -9.74 40.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -76.37 -36.91 57.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.17 -32.89 4.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.4 39.31 3.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.518 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.28 -179.99 4.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 0.0 110.872 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.18 138.46 28.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.55 ' CE1' HD13 ' A' ' 211' ' ' LEU . 10.5 m-85 -133.21 163.96 28.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.7 m -101.9 -21.77 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.855 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -123.58 138.94 54.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -56.53 20.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.68 -45.13 24.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.504 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.41 -39.79 58.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.888 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 211' ' ' LEU . 9.3 tp -71.38 -32.4 68.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.582 ' HA ' HD12 ' A' ' 215' ' ' ILE . 17.3 mt -60.89 -31.77 50.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.137 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 213' ' ' VAL . 20.9 t -78.33 -10.97 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.718 ' O ' HG22 ' A' ' 217' ' ' VAL . 11.7 t60 -94.55 -31.32 13.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 212' ' ' ILE . 56.5 mt -56.71 -21.59 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.1 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -55.48 -25.82 39.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.2 m -82.17 -25.14 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -98.59 -74.92 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.2 m -104.71 151.07 24.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.27 103.2 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.484 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.0 t -123.15 46.95 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 110.898 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -170.79 67.28 0.15 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.509 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 165.23 31.66 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.68 2.253 . . . . 0.0 112.311 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.1 m 61.89 166.79 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.9 t 61.78 167.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 CA-C-O 119.125 -0.82 . . . . 0.0 112.504 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 50.7 m -96.62 55.55 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 110.873 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.0 t -52.38 -37.02 55.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.898 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 73.37 101.81 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.53 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.6 p -70.89 142.59 51.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 110.894 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 64.7 p -176.46 -177.61 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 128.84 137.31 4.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.53 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.34 -150.71 2.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -131.24 24.06 4.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -115.87 155.72 47.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.589 0.709 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -28.31 25.33 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.71 2.273 . . . . 0.0 112.305 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -82.8 104.58 13.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.36 109.13 5.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.0 130.42 43.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.4 -9.46 41.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -76.6 -36.88 57.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.19 -32.87 4.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.27 40.65 3.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.517 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -101.31 -179.71 4.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.19 139.21 28.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.098 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.55 ' CE1' HD13 ' A' ' 211' ' ' LEU . 11.2 m-85 -133.43 164.44 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.2 m -102.45 -21.65 14.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -123.6 139.57 53.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.94 -56.93 15.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.71 -44.82 23.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.443 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.5 m -51.44 -40.23 58.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.905 0.384 . . . . 0.0 110.825 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 211' ' ' LEU . 9.0 tp -71.05 -32.62 69.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.572 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.9 mt -60.67 -31.8 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.2 t -78.29 -10.98 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.148 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.728 ' O ' HG22 ' A' ' 217' ' ' VAL . 11.6 t60 -94.54 -31.38 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 212' ' ' ILE . 56.6 mt -57.17 -21.34 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.12 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -55.52 -26.03 40.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.3 m -82.34 -24.53 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.155 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -98.43 -74.71 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.47 151.2 25.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -50.86 103.2 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.509 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 17.7 t -117.02 68.45 0.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.909 0.385 . . . . 0.0 110.811 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 151.79 168.03 15.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.454 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 84.17 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 6.8 p -53.88 -32.49 53.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.02 46.06 27.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.848 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 CA-C-O 119.153 -0.804 . . . . 0.0 112.461 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 28.9 t -80.53 80.59 6.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 110.865 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 22.8 t -138.62 101.67 4.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 172.28 38.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.457 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t -80.4 93.12 5.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.917 0.389 . . . . 0.0 110.894 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.0 m -150.11 152.96 35.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.844 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 52.18 85.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -153.77 117.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.465 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -175.13 -36.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.368 . . . . 0.0 110.877 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.32 155.35 92.64 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.62 0.724 . . . . 0.0 110.879 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -27.24 26.97 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.698 2.265 . . . . 0.0 112.38 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -84.13 105.04 14.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -142.53 106.56 4.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.885 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -63.43 129.39 40.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -91.08 -9.4 45.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.56 -37.01 57.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.11 -32.86 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.21 38.81 3.93 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.489 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -98.29 -179.73 4.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 0.0 110.903 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -143.86 138.8 28.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.082 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.538 ' CE1' HD13 ' A' ' 211' ' ' LEU . 12.6 m-85 -133.93 164.15 27.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 5.1 m -102.44 -21.36 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -124.22 141.29 52.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -56.91 16.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.52 -44.96 22.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.519 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.47 -39.95 58.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 110.83 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 211' ' ' LEU . 9.5 tp -71.41 -32.27 68.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.93 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.574 ' HA ' HD12 ' A' ' 215' ' ' ILE . 17.9 mt -61.15 -31.64 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.8 t -78.54 -10.96 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.075 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.722 ' O ' HG22 ' A' ' 217' ' ' VAL . 10.6 t60 -94.19 -31.2 14.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 212' ' ' ILE . 54.8 mt -57.15 -21.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.092 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.7 mtt-85 -55.47 -25.92 39.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.829 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.0 m -82.35 -25.13 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.131 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -97.56 -74.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.03 151.19 26.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.14 103.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.9 t -118.92 144.63 46.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 0.0 110.903 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 166.18 -174.93 41.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.438 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 146.97 62.09 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.702 2.268 . . . . 0.0 112.343 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 11.3 m 63.03 -177.63 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 88.9 p -104.93 57.96 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 CA-C-O 119.157 -0.802 . . . . 0.0 112.479 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.5 t -171.08 93.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 0.0 110.844 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.67 168.53 13.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -168.01 77.28 0.11 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 42.1 p -117.5 156.36 28.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.845 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.3 t -153.21 157.34 40.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 111.99 170.14 18.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.498 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 128.62 57.4 0.11 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.466 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.12 -28.88 13.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 0.0 110.856 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.73 156.24 35.48 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.595 0.712 . . . . 0.0 110.89 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -25.15 29.01 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.705 2.27 . . . . 0.0 112.326 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -86.27 103.82 15.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -141.68 107.19 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 12.3 t -64.9 129.06 38.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.924 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.33 -11.93 39.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -73.0 -37.36 67.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -120.24 -32.93 4.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.6 38.56 3.9 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -98.06 -179.97 4.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.8 137.73 26.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.056 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.575 ' CE1' HD13 ' A' ' 211' ' ' LEU . 9.8 m-85 -133.04 164.06 27.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.98 -21.67 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -123.07 138.81 54.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -56.97 15.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.43 -45.65 22.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.45 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.63 -38.09 53.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 110.842 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.575 HD13 ' CE1' ' A' ' 205' ' ' PHE . 14.0 tp -73.24 -31.02 63.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.435 ' HA ' HD12 ' A' ' 215' ' ' ILE . 18.7 mt -62.88 -30.27 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.0 t -80.03 -10.85 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.749 ' O ' HG22 ' A' ' 217' ' ' VAL . 9.6 t60 -93.46 -33.24 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 212' ' ' ILE . 55.4 mt -59.39 -19.79 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -55.45 -25.0 33.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 214' ' ' HIS . 12.8 m -86.13 -24.54 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -92.33 -75.05 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.98 151.01 22.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.147 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.66 102.99 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.47 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.41 102.19 9.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.927 0.394 . . . . 0.0 110.866 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 62.0 166.82 0.52 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.481 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 172.81 11.93 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.318 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 49.4 m -154.29 151.58 29.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 50.7 m -73.71 -49.63 24.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 119.182 -0.788 . . . . 0.0 112.524 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 67.1 p -166.15 -179.44 5.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.885 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.7 t -135.93 91.51 2.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.797 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -147.73 161.67 28.58 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.473 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 62.1 m -68.47 -26.31 65.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.902 0.382 . . . . 0.0 110.871 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 m 63.16 92.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.86 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.63 -150.7 19.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.5 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 140.98 132.93 2.88 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.454 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.1 53.7 1.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.946 0.403 . . . . 0.0 110.882 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -106.45 156.5 36.91 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.549 0.69 . . . . 0.0 110.859 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -26.19 27.56 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.674 2.249 . . . . 0.0 112.349 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -83.59 101.74 11.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -136.87 111.26 8.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.93 126.09 28.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -88.34 -10.93 47.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -73.01 -38.81 66.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.77 -33.15 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.5 48.1 2.05 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -111.66 -178.64 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.2 140.53 34.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.644 ' CE1' HD13 ' A' ' 211' ' ' LEU . 15.9 m-85 -131.77 153.6 49.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.9 m -87.33 -27.09 23.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -123.58 157.05 34.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -54.68 10.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.97 -45.58 26.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.497 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.5 m -51.98 -36.29 49.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.839 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.644 HD13 ' CE1' ' A' ' 205' ' ' PHE . 13.2 tp -74.86 -31.75 61.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.7 mt -62.65 -27.6 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.26 -10.73 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.09 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.761 ' O ' HG22 ' A' ' 217' ' ' VAL . 9.1 t60 -93.9 -36.8 12.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.58 -19.87 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.154 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -59.42 -20.7 57.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 214' ' ' HIS . 5.9 m -98.02 8.11 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -114.8 -75.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.85 90.71 3.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 51.29 -106.98 0.34 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.485 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.76 88.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.38 . . . . 0.0 110.844 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.09 75.58 1.31 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 125.73 12.48 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.655 2.237 . . . . 0.0 112.36 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 74.5 p -123.76 164.26 19.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.83 36.38 4.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.859 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 119.106 -0.83 . . . . 0.0 112.499 -179.962 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.16 -26.98 14.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.914 0.388 . . . . 0.0 110.887 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m 62.93 -177.57 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.878 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 103.06 47.77 1.31 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.463 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.46 149.83 23.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.925 0.393 . . . . 0.0 110.794 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 82.1 p -103.94 74.54 1.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.853 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -102.42 -95.81 2.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.504 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 55.11 68.79 1.5 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.491 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -102.11 -26.52 13.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.391 . . . . 0.0 110.884 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.25 155.72 74.34 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.571 0.7 . . . . 0.0 110.872 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -26.7 27.57 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.738 2.292 . . . . 0.0 112.367 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -84.74 106.36 16.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -142.94 107.0 4.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.4 t -64.53 130.15 42.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.858 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -92.04 -9.52 42.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.847 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -76.44 -36.88 57.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.946 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.32 -32.85 4.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.01 39.83 3.7 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.481 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -100.31 -179.82 4.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.1 140.08 29.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.085 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.529 ' CE1' HD13 ' A' ' 211' ' ' LEU . 12.1 m-85 -134.08 163.87 28.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 71.0 m -100.68 -22.42 14.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.819 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -123.43 144.26 49.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.416 ' HD2' HD11 ' A' ' 212' ' ' ILE . 2.3 tmtm? -61.46 -57.29 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -46.94 -44.31 18.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.463 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.5 m -51.63 -40.01 59.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 110.872 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.529 HD13 ' CE1' ' A' ' 205' ' ' PHE . 10.5 tp -72.0 -32.86 67.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.475 ' HA ' HD12 ' A' ' 215' ' ' ILE . 17.9 mt -60.99 -29.43 45.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 213' ' ' VAL . 19.9 t -81.53 -10.81 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.74 ' O ' HG22 ' A' ' 217' ' ' VAL . 10.1 t60 -94.35 -33.66 13.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 212' ' ' ILE . 54.9 mt -57.92 -20.61 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -55.33 -25.26 33.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 214' ' ' HIS . 11.4 m -84.5 -25.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -93.09 -74.71 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.24 151.03 24.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.4 102.9 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.47 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.97 -26.1 7.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 110.84 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -161.84 165.7 35.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -171.15 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.685 2.256 . . . . 0.0 112.332 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 16.5 p -97.95 87.5 4.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.9 p -87.43 -63.07 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.903 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 119.124 -0.82 . . . . 0.0 112.476 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.4 m -120.07 94.88 4.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 0.0 110.855 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.55 -170.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.842 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 147.57 141.38 3.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.8 p -146.57 177.58 8.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.89 0.376 . . . . 0.0 110.87 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.2 p -170.38 152.06 3.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.892 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.37 30.57 8.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.541 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 178.36 119.72 0.62 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.475 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -138.35 137.57 37.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 110.899 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -66.13 155.37 87.63 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.524 0.678 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -25.16 28.79 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.672 2.248 . . . . 0.0 112.349 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -85.81 99.95 11.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -135.09 111.57 9.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.2 t -68.71 128.04 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.57 -12.43 39.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.81 -38.55 70.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -118.82 -32.94 4.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.08 50.35 1.93 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.86 -178.56 3.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.792 0.329 . . . . 0.0 110.928 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.7 139.18 34.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.073 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.592 ' CE1' HD13 ' A' ' 211' ' ' LEU . 17.2 m-85 -129.48 150.71 50.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 56.0 p -82.89 -28.78 29.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.65 162.41 23.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -53.85 8.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.7 -46.07 24.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.482 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.36 -37.58 48.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.901 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.592 HD13 ' CE1' ' A' ' 205' ' ' PHE . 15.0 tp -73.7 -31.7 63.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.928 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 18.9 mt -61.93 -29.11 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 213' ' ' VAL . 19.8 t -83.43 -10.88 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.753 ' O ' HG22 ' A' ' 217' ' ' VAL . 10.0 t60 -95.09 -40.32 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 53.1 mt -57.79 -20.46 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -59.26 -21.19 59.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 214' ' ' HIS . 5.4 m -97.46 7.45 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -113.25 -74.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 50.4 m -119.18 90.86 3.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 51.85 -107.19 0.42 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.494 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.75 88.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.938 0.399 . . . . 0.0 110.85 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 90.49 173.07 44.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.471 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 138.45 37.89 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.714 2.276 . . . . 0.0 112.387 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 70.4 m -101.75 90.71 4.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.4 m -116.4 -57.76 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.829 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 119.159 -0.801 . . . . 0.0 112.507 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 47.0 m -88.87 -45.13 9.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.936 0.398 . . . . 0.0 110.884 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.4 t -126.42 -45.52 1.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.841 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 142.95 66.09 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.503 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 61.8 p -145.91 176.52 9.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 110.85 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.2 m -115.17 -32.73 5.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.831 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -86.42 -134.03 3.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.461 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -137.29 162.92 25.41 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.463 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -53.74 -62.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 110.889 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -115.85 154.56 48.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.587 0.708 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -26.86 27.04 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.708 2.272 . . . . 0.0 112.33 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.19 110.53 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -144.94 104.38 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -62.9 127.25 30.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.58 -9.25 50.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -76.35 -37.26 57.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.36 -32.98 3.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.37 41.55 3.41 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -102.19 -179.35 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.341 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -143.11 142.28 31.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.476 ' CE1' HD13 ' A' ' 211' ' ' LEU . 14.7 m-85 -135.86 162.5 32.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.0 -23.19 16.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -125.82 150.9 47.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.941 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -54.34 24.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.95 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.7 -46.26 24.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.447 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -51.29 -39.54 57.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 110.907 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 211' ' ' LEU . 9.6 tp -70.86 -32.03 68.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.951 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.527 ' HA ' HD12 ' A' ' 215' ' ' ILE . 17.0 mt -61.45 -31.94 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.091 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.0 t -78.95 -10.84 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.71 ' O ' HG22 ' A' ' 217' ' ' VAL . 11.2 t60 -93.73 -31.89 14.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 212' ' ' ILE . 57.1 mt -56.7 -21.61 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.135 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -54.87 -26.22 34.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.8 m -81.49 -27.12 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.116 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -96.39 -74.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.86 150.98 22.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.78 103.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.16 25.23 5.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.95 0.405 . . . . 0.0 110.866 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -174.31 -69.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.491 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 126.81 13.74 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.642 2.228 . . . . 0.0 112.392 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.28 -50.52 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.822 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 78.1 p -127.94 166.07 19.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 CA-C-O 119.12 -0.822 . . . . 0.0 112.5 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.98 98.42 3.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.86 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.9 p -133.8 125.43 28.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -149.83 -77.38 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.499 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.8 161.0 40.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.2 t -106.86 -56.42 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.849 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.91 147.65 6.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.61 142.16 41.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.449 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -55.99 -26.91 50.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -100.73 156.43 35.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.65 0.738 . . . . 0.0 110.885 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -27.13 26.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.671 2.248 . . . . 0.0 112.361 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -82.45 101.61 10.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -136.69 111.26 8.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 16.0 t -69.12 124.51 23.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.71 -11.16 52.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.41 -40.07 67.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.974 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -117.81 -33.2 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.81 48.12 1.99 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.518 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -111.63 -178.73 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.71 140.98 34.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.13 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.651 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.8 m-85 -132.24 153.22 50.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.3 p -86.5 -27.6 23.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.854 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -123.91 159.66 29.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -72.89 -54.5 8.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.8 -45.96 24.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.466 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.8 m -51.8 -36.24 47.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.917 0.389 . . . . 0.0 110.85 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.651 HD13 ' CE1' ' A' ' 205' ' ' PHE . 14.0 tp -74.92 -32.28 61.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.2 mt -62.36 -26.94 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 19.6 t -84.74 -10.8 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.76 ' O ' HG22 ' A' ' 217' ' ' VAL . 8.7 t60 -94.35 -36.74 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.28 -20.03 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -59.32 -20.6 55.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 214' ' ' HIS . 5.8 m -98.38 10.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.127 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -117.11 -75.07 0.58 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.22 90.82 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 51.06 -108.51 0.56 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.507 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.09 26.08 7.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.851 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 179.32 -75.73 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.497 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 178.35 4.61 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.727 2.284 . . . . 0.0 112.369 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.07 143.24 27.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 17.3 p -81.05 -44.56 17.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 CA-C-O 119.144 -0.809 . . . . 0.0 112.453 179.999 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? . . . . . 0 C--O 1.231 0.081 0 CA-C-O 121.58 0.705 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -25.27 28.99 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 0.0 112.365 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -84.96 101.12 12.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.954 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 31.7 ttp85 -137.83 111.16 7.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -66.7 129.49 40.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -91.78 -9.32 44.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -76.38 -36.96 57.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.15 -32.76 4.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.96 46.63 2.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -108.54 -179.38 3.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.32 141.4 33.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.066 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.581 ' CE1' HD13 ' A' ' 211' ' ' LEU . 15.2 m-85 -134.13 153.51 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.15 -28.47 25.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -123.52 162.78 22.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -53.1 9.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.97 -46.3 26.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 m -51.63 -38.6 55.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.87 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.581 HD13 ' CE1' ' A' ' 205' ' ' PHE . 9.7 tp -71.42 -32.26 68.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.955 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.539 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.5 mt -60.95 -32.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.404 ' O ' HG12 ' A' ' 213' ' ' VAL . 20.6 t -77.9 -10.74 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.722 ' O ' HG22 ' A' ' 217' ' ' VAL . 12.7 t60 -94.05 -32.51 13.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 212' ' ' ILE . 55.4 mt -56.72 -21.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.184 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -55.09 -26.14 35.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.5 m -82.51 -26.07 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -95.96 -74.07 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.153 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.596 0.713 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -24.42 29.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.232 . . . . 0.0 112.367 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -86.49 100.71 12.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -136.48 111.39 8.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.5 t -67.43 129.93 41.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.52 -9.31 41.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.838 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -76.12 -36.68 58.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.06 -32.72 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.15 50.23 1.94 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.75 -179.01 3.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.11 140.21 34.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.604 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.5 m-85 -131.02 151.45 51.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.942 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.79 -29.25 29.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.823 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -123.19 164.91 17.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.17 -53.05 8.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.11 -45.73 26.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.49 -39.4 57.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.844 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.604 HD13 ' CE1' ' A' ' 205' ' ' PHE . 12.2 tp -71.03 -32.9 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.53 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.8 mt -60.03 -32.45 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.0 t -79.12 -10.88 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.717 ' O ' HG22 ' A' ' 217' ' ' VAL . 15.1 t60 -94.01 -32.88 13.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.862 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.53 HD12 ' HA ' ' A' ' 212' ' ' ILE . 58.0 mt -56.39 -21.76 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -55.21 -25.93 36.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.2 m -82.42 -25.6 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -97.66 -74.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.184 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.552 0.691 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -24.74 29.69 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 0.0 112.368 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -86.02 100.61 12.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -136.75 111.31 8.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.8 130.65 43.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -92.48 -10.22 38.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.865 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -75.64 -36.94 60.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.88 -32.9 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.17 47.84 2.34 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -110.09 -179.2 3.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.799 0.333 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.66 140.12 34.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.079 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.6 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.4 m-85 -131.84 151.68 51.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.4 -29.03 28.48 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.831 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -123.18 164.77 18.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -53.08 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.23 -45.55 27.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.537 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.63 -39.38 57.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.848 0.356 . . . . 0.0 110.835 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.6 HD13 ' CE1' ' A' ' 205' ' ' PHE . 11.5 tp -71.01 -32.91 69.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.549 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.7 mt -60.0 -32.62 50.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.2 t -78.83 -10.79 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.094 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.719 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.2 t60 -94.18 -32.35 13.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 212' ' ' ILE . 56.0 mt -56.45 -21.68 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -55.52 -25.73 39.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.1 m -82.5 -24.88 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -98.5 -74.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.105 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.543 0.687 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -24.58 29.39 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.685 2.257 . . . . 0.0 112.36 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -86.19 100.63 12.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -136.04 111.3 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.851 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -67.32 130.15 42.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -92.5 -9.26 42.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -76.43 -37.44 57.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.43 -32.77 4.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.04 49.81 2.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.91 -179.05 3.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 0.0 110.935 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.82 139.75 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.596 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.2 m-85 -130.61 151.43 51.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 83.7 p -83.1 -28.93 29.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.78 163.8 20.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.937 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -76.03 -53.12 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.84 -45.87 25.25 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.455 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.52 -39.11 57.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 0.0 110.808 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.596 HD13 ' CE1' ' A' ' 205' ' ' PHE . 12.3 tp -71.36 -33.34 69.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.7 mt -59.68 -32.08 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 20.7 t -79.78 -10.87 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.724 ' O ' HG22 ' A' ' 217' ' ' VAL . 15.4 t60 -94.04 -33.19 13.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 212' ' ' ILE . 55.8 mt -56.51 -21.69 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -55.36 -25.86 37.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.1 m -82.72 -25.09 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -97.53 -74.19 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.579 0.704 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -24.51 29.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 0.0 112.355 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -86.5 100.54 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.43 111.34 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.5 t -67.47 130.18 42.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -92.56 -9.91 39.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -75.51 -36.6 60.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.17 -32.76 4.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.04 50.11 1.97 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -113.59 -179.02 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.85 140.37 34.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.075 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.605 ' CE1' HD13 ' A' ' 211' ' ' LEU . 17.1 m-85 -131.07 151.42 51.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 38.7 t -83.05 -29.03 29.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -123.17 164.8 18.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -53.22 8.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.921 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.28 -45.32 28.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.49 -39.67 58.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.877 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.605 HD13 ' CE1' ' A' ' 205' ' ' PHE . 12.7 tp -70.89 -33.13 70.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.915 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.524 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.3 mt -59.7 -32.54 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.1 t -79.23 -10.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.718 ' O ' HG22 ' A' ' 217' ' ' VAL . 15.0 t60 -94.02 -32.64 13.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.856 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 212' ' ' ILE . 59.0 mt -56.41 -21.79 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -55.4 -25.79 37.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 214' ' ' HIS . 9.6 m -82.43 -25.08 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -98.48 -74.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.162 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.56 0.695 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -23.99 29.94 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.693 2.262 . . . . 0.0 112.339 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -86.91 103.59 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -138.05 110.59 7.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -66.5 130.38 42.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.48 -9.29 41.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.852 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -76.66 -37.39 56.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -119.66 -32.94 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.81 49.02 2.19 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.455 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -111.67 -178.97 3.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.36 141.18 35.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.09 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.591 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.7 m-85 -132.32 151.35 51.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.15 -28.98 29.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -123.31 163.72 20.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -53.16 8.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.29 -45.57 28.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.3 m -51.52 -39.24 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.862 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.591 HD13 ' CE1' ' A' ' 205' ' ' PHE . 11.3 tp -71.16 -33.07 69.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.958 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.1 mt -59.89 -32.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.089 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.1 t -79.35 -10.87 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.724 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.5 t60 -94.17 -32.33 13.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.832 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 212' ' ' ILE . 58.7 mt -56.8 -21.56 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.108 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -55.4 -25.72 37.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.3 m -82.77 -24.96 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.079 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -98.34 -75.0 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.571 0.701 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -24.06 30.06 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.642 2.228 . . . . 0.0 112.394 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -87.14 100.26 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -135.05 111.36 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -67.25 130.37 42.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.49 -9.29 41.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -76.6 -37.7 56.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.17 -32.8 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.41 50.45 2.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.458 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.58 -178.99 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.49 139.52 35.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.606 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.2 m-85 -130.01 149.91 51.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 98.1 p -81.41 -29.57 33.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.19 164.49 18.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -76.55 -53.74 7.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.64 -45.68 23.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.493 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.3 m -51.5 -38.74 55.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.942 0.401 . . . . 0.0 110.887 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.606 HD13 ' CE1' ' A' ' 205' ' ' PHE . 15.0 tp -72.23 -32.83 67.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.518 ' HA ' HD12 ' A' ' 215' ' ' ILE . 18.3 mt -60.34 -30.63 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.8 t -81.39 -10.84 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.718 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.5 t60 -93.63 -32.85 13.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 212' ' ' ILE . 54.6 mt -56.66 -21.57 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -54.93 -26.0 33.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.7 m -82.45 -26.56 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -96.51 -74.82 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.518 0.675 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -23.55 30.64 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.708 2.272 . . . . 0.0 112.309 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -87.72 100.34 12.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.79 111.45 9.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -67.54 129.89 41.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.46 -9.24 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -76.23 -36.87 58.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.04 -32.84 4.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.85 50.53 1.93 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -178.83 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.333 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.06 140.04 34.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.067 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.622 ' CE1' HD13 ' A' ' 211' ' ' LEU . 15.5 m-85 -129.99 150.16 51.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.83 -29.59 35.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -123.26 165.37 17.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -52.78 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.31 -45.57 28.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.52 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.69 -38.84 56.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.862 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.622 HD13 ' CE1' ' A' ' 205' ' ' PHE . 12.4 tp -71.5 -32.56 68.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.93 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.435 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.0 mt -60.45 -32.27 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.3 t -80.2 -10.7 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.744 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.7 t60 -92.93 -33.87 14.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 212' ' ' ILE . 55.0 mt -58.23 -20.49 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -55.27 -25.42 33.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 214' ' ' HIS . 11.5 m -85.24 -24.89 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.121 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -93.86 -74.71 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.139 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.592 0.71 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -15.99 37.16 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.677 2.251 . . . . 0.0 112.32 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -95.52 99.73 11.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -135.09 111.64 9.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -66.94 131.19 45.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -92.45 -13.2 30.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -72.21 -36.47 69.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.7 p -120.21 -32.76 4.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 94.54 50.81 2.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.472 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -114.12 -179.24 3.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.771 0.32 . . . . 0.0 110.926 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -138.79 137.77 36.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.618 ' CE1' HD13 ' A' ' 211' ' ' LEU . 18.4 m-85 -127.87 144.85 51.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.8 t -75.83 -31.28 59.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -123.12 164.87 17.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -76.25 -52.59 9.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.2 -45.17 27.48 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.499 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -39.49 58.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.848 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.618 HD13 ' CE1' ' A' ' 205' ' ' PHE . 13.9 tp -71.1 -33.79 70.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.503 ' HA ' HD12 ' A' ' 215' ' ' ILE . 15.7 mt -58.89 -31.92 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.6 t -80.98 -10.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.169 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.709 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.0 t60 -93.42 -31.9 14.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 212' ' ' ILE . 58.2 mt -56.34 -21.98 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -55.51 -25.64 38.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 214' ' ' HIS . 9.0 m -81.98 -25.62 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -98.69 -74.95 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.846 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.615 0.721 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -15.63 37.06 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.658 2.239 . . . . 0.0 112.367 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -96.65 99.6 11.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.79 111.59 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.87 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.7 t -67.44 131.08 44.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -92.42 -12.64 31.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -72.78 -36.86 67.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.8 p -119.93 -32.57 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.854 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 94.52 50.88 2.09 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -114.09 -179.27 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.04 136.44 33.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.604 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.3 m-85 -126.52 146.97 49.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.59 -30.64 52.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.59 165.36 16.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -52.92 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.21 -45.38 27.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.467 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.55 -39.55 57.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.902 0.382 . . . . 0.0 110.82 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.604 HD13 ' CE1' ' A' ' 205' ' ' PHE . 14.2 tp -70.99 -33.16 70.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.495 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.5 mt -59.6 -32.37 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 213' ' ' VAL . 21.0 t -80.38 -10.73 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.717 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.2 t60 -93.26 -32.16 14.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 212' ' ' ILE . 58.6 mt -56.58 -21.78 13.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -55.5 -25.71 38.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 214' ' ' HIS . 9.5 m -82.3 -25.03 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.132 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -98.95 -75.07 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.562 0.696 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.77 -24.82 29.2 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.675 2.25 . . . . 0.0 112.309 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -85.73 100.62 12.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -136.12 111.43 9.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 10.1 t -67.76 130.35 42.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.34 -10.16 39.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -75.28 -36.67 61.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.33 -33.1 3.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.54 48.42 2.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -111.34 -178.8 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.788 0.328 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.71 139.11 32.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.592 ' CE1' HD13 ' A' ' 211' ' ' LEU . 15.5 m-85 -130.14 152.65 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 27.4 t -83.77 -29.04 27.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -123.41 163.86 20.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.3 -52.66 9.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.11 -46.23 27.0 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 m -51.66 -38.62 55.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.592 HD13 ' CE1' ' A' ' 205' ' ' PHE . 11.6 tp -71.43 -32.17 68.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.7 mt -60.95 -33.03 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.3 t -79.11 -10.8 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.749 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.8 t60 -93.32 -36.48 12.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.75 -19.92 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -23.92 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 214' ' ' HIS . 11.5 m -87.75 -23.8 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -91.14 -74.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 -179.91 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.578 0.704 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -26.09 28.13 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.706 2.27 . . . . 0.0 112.339 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -85.14 104.21 14.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.877 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 108.75 5.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -65.34 130.7 44.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.51 -9.74 40.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -76.37 -36.91 57.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.17 -32.89 4.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.4 39.31 3.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.518 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.28 -179.99 4.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 0.0 110.872 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.18 138.46 28.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.55 ' CE1' HD13 ' A' ' 211' ' ' LEU . 10.5 m-85 -133.21 163.96 28.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.7 m -101.9 -21.77 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.855 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -123.58 138.94 54.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -56.53 20.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.68 -45.13 24.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.504 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.41 -39.79 58.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.888 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 211' ' ' LEU . 9.3 tp -71.38 -32.4 68.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.582 ' HA ' HD12 ' A' ' 215' ' ' ILE . 17.3 mt -60.89 -31.77 50.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.137 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 213' ' ' VAL . 20.9 t -78.33 -10.97 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.718 ' O ' HG22 ' A' ' 217' ' ' VAL . 11.7 t60 -94.55 -31.32 13.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 212' ' ' ILE . 56.5 mt -56.71 -21.59 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.1 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -55.48 -25.82 39.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.2 m -82.17 -25.14 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -98.59 -74.92 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 -179.942 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.589 0.709 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -28.31 25.33 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.71 2.273 . . . . 0.0 112.305 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -82.8 104.58 13.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.36 109.13 5.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.0 130.42 43.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.4 -9.46 41.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -76.6 -36.88 57.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.19 -32.87 4.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.27 40.65 3.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.517 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -101.31 -179.71 4.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.19 139.21 28.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.098 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.55 ' CE1' HD13 ' A' ' 211' ' ' LEU . 11.2 m-85 -133.43 164.44 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.2 m -102.45 -21.65 14.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -123.6 139.57 53.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.94 -56.93 15.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.71 -44.82 23.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.443 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.5 m -51.44 -40.23 58.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.905 0.384 . . . . 0.0 110.825 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 211' ' ' LEU . 9.0 tp -71.05 -32.62 69.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.572 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.9 mt -60.67 -31.8 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.2 t -78.29 -10.98 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.148 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.728 ' O ' HG22 ' A' ' 217' ' ' VAL . 11.6 t60 -94.54 -31.38 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 212' ' ' ILE . 56.6 mt -57.17 -21.34 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.12 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -55.52 -26.03 40.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.3 m -82.34 -24.53 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.155 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -98.43 -74.71 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.62 0.724 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -27.24 26.97 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.698 2.265 . . . . 0.0 112.38 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -84.13 105.04 14.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -142.53 106.56 4.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.885 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -63.43 129.39 40.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -91.08 -9.4 45.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.56 -37.01 57.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.11 -32.86 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.21 38.81 3.93 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.489 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -98.29 -179.73 4.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 0.0 110.903 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -143.86 138.8 28.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.082 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.538 ' CE1' HD13 ' A' ' 211' ' ' LEU . 12.6 m-85 -133.93 164.15 27.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 5.1 m -102.44 -21.36 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -124.22 141.29 52.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -56.91 16.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.52 -44.96 22.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.519 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.47 -39.95 58.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 110.83 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 211' ' ' LEU . 9.5 tp -71.41 -32.27 68.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.93 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.574 ' HA ' HD12 ' A' ' 215' ' ' ILE . 17.9 mt -61.15 -31.64 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.8 t -78.54 -10.96 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.075 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.722 ' O ' HG22 ' A' ' 217' ' ' VAL . 10.6 t60 -94.19 -31.2 14.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 212' ' ' ILE . 54.8 mt -57.15 -21.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.092 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.7 mtt-85 -55.47 -25.92 39.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.829 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.0 m -82.35 -25.13 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.131 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -97.56 -74.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.595 0.712 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -25.15 29.01 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.705 2.27 . . . . 0.0 112.326 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -86.27 103.82 15.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -141.68 107.19 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 12.3 t -64.9 129.06 38.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.924 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.33 -11.93 39.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -73.0 -37.36 67.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -120.24 -32.93 4.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.6 38.56 3.9 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -98.06 -179.97 4.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.8 137.73 26.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.056 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.575 ' CE1' HD13 ' A' ' 211' ' ' LEU . 9.8 m-85 -133.04 164.06 27.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.98 -21.67 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -123.07 138.81 54.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -56.97 15.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.43 -45.65 22.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.45 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.63 -38.09 53.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 110.842 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.575 HD13 ' CE1' ' A' ' 205' ' ' PHE . 14.0 tp -73.24 -31.02 63.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.435 ' HA ' HD12 ' A' ' 215' ' ' ILE . 18.7 mt -62.88 -30.27 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.0 t -80.03 -10.85 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.749 ' O ' HG22 ' A' ' 217' ' ' VAL . 9.6 t60 -93.46 -33.24 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 212' ' ' ILE . 55.4 mt -59.39 -19.79 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -55.45 -25.0 33.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 214' ' ' HIS . 12.8 m -86.13 -24.54 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -92.33 -75.05 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.147 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.549 0.69 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -26.19 27.56 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.674 2.249 . . . . 0.0 112.349 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -83.59 101.74 11.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -136.87 111.26 8.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.93 126.09 28.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -88.34 -10.93 47.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -73.01 -38.81 66.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.77 -33.15 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.5 48.1 2.05 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -111.66 -178.64 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.2 140.53 34.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.644 ' CE1' HD13 ' A' ' 211' ' ' LEU . 15.9 m-85 -131.77 153.6 49.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.9 m -87.33 -27.09 23.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -123.58 157.05 34.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -54.68 10.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.97 -45.58 26.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.497 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.5 m -51.98 -36.29 49.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.839 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.644 HD13 ' CE1' ' A' ' 205' ' ' PHE . 13.2 tp -74.86 -31.75 61.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.7 mt -62.65 -27.6 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.26 -10.73 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.09 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.761 ' O ' HG22 ' A' ' 217' ' ' VAL . 9.1 t60 -93.9 -36.8 12.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.58 -19.87 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.154 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -59.42 -20.7 57.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 214' ' ' HIS . 5.9 m -98.02 8.11 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -114.8 -75.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.571 0.7 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -26.7 27.57 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.738 2.292 . . . . 0.0 112.367 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -84.74 106.36 16.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -142.94 107.0 4.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.4 t -64.53 130.15 42.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.858 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -92.04 -9.52 42.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.847 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -76.44 -36.88 57.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.946 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.32 -32.85 4.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.01 39.83 3.7 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.481 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -100.31 -179.82 4.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.1 140.08 29.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.085 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.529 ' CE1' HD13 ' A' ' 211' ' ' LEU . 12.1 m-85 -134.08 163.87 28.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 71.0 m -100.68 -22.42 14.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.819 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -123.43 144.26 49.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.416 ' HD2' HD11 ' A' ' 212' ' ' ILE . 2.3 tmtm? -61.46 -57.29 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -46.94 -44.31 18.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.463 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.5 m -51.63 -40.01 59.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 110.872 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.529 HD13 ' CE1' ' A' ' 205' ' ' PHE . 10.5 tp -72.0 -32.86 67.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.475 ' HA ' HD12 ' A' ' 215' ' ' ILE . 17.9 mt -60.99 -29.43 45.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 213' ' ' VAL . 19.9 t -81.53 -10.81 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.74 ' O ' HG22 ' A' ' 217' ' ' VAL . 10.1 t60 -94.35 -33.66 13.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 212' ' ' ILE . 54.9 mt -57.92 -20.61 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -55.33 -25.26 33.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 214' ' ' HIS . 11.4 m -84.5 -25.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -93.09 -74.71 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.524 0.678 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -25.16 28.79 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.672 2.248 . . . . 0.0 112.349 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -85.81 99.95 11.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -135.09 111.57 9.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.2 t -68.71 128.04 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.57 -12.43 39.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.81 -38.55 70.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -118.82 -32.94 4.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.08 50.35 1.93 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.86 -178.56 3.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.792 0.329 . . . . 0.0 110.928 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.7 139.18 34.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.073 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.592 ' CE1' HD13 ' A' ' 211' ' ' LEU . 17.2 m-85 -129.48 150.71 50.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 56.0 p -82.89 -28.78 29.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.65 162.41 23.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -53.85 8.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.7 -46.07 24.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.482 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.36 -37.58 48.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.901 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.592 HD13 ' CE1' ' A' ' 205' ' ' PHE . 15.0 tp -73.7 -31.7 63.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.928 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 18.9 mt -61.93 -29.11 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 213' ' ' VAL . 19.8 t -83.43 -10.88 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.753 ' O ' HG22 ' A' ' 217' ' ' VAL . 10.0 t60 -95.09 -40.32 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 53.1 mt -57.79 -20.46 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -59.26 -21.19 59.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 214' ' ' HIS . 5.4 m -97.46 7.45 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -113.25 -74.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 50.4 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 -179.894 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.587 0.708 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -26.86 27.04 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.708 2.272 . . . . 0.0 112.33 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.19 110.53 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -144.94 104.38 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -62.9 127.25 30.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.58 -9.25 50.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -76.35 -37.26 57.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.36 -32.98 3.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.37 41.55 3.41 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -102.19 -179.35 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.341 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -143.11 142.28 31.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.476 ' CE1' HD13 ' A' ' 211' ' ' LEU . 14.7 m-85 -135.86 162.5 32.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.0 -23.19 16.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -125.82 150.9 47.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.941 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -54.34 24.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.95 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.7 -46.26 24.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.447 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -51.29 -39.54 57.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 110.907 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 211' ' ' LEU . 9.6 tp -70.86 -32.03 68.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.951 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.527 ' HA ' HD12 ' A' ' 215' ' ' ILE . 17.0 mt -61.45 -31.94 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.091 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.0 t -78.95 -10.84 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.71 ' O ' HG22 ' A' ' 217' ' ' VAL . 11.2 t60 -93.73 -31.89 14.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 212' ' ' ILE . 57.1 mt -56.7 -21.61 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.135 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -54.87 -26.22 34.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.8 m -81.49 -27.12 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.116 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -96.39 -74.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.65 0.738 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -27.13 26.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.671 2.248 . . . . 0.0 112.361 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -82.45 101.61 10.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -136.69 111.26 8.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 16.0 t -69.12 124.51 23.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.71 -11.16 52.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.41 -40.07 67.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.974 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -117.81 -33.2 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.81 48.12 1.99 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.518 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -111.63 -178.73 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.71 140.98 34.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.13 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.651 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.8 m-85 -132.24 153.22 50.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.3 p -86.5 -27.6 23.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.854 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -123.91 159.66 29.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -72.89 -54.5 8.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.8 -45.96 24.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.466 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.8 m -51.8 -36.24 47.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.917 0.389 . . . . 0.0 110.85 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.651 HD13 ' CE1' ' A' ' 205' ' ' PHE . 14.0 tp -74.92 -32.28 61.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.2 mt -62.36 -26.94 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 19.6 t -84.74 -10.8 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.76 ' O ' HG22 ' A' ' 217' ' ' VAL . 8.7 t60 -94.35 -36.74 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.28 -20.03 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -59.32 -20.6 55.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 214' ' ' HIS . 5.8 m -98.38 10.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.127 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -117.11 -75.07 0.58 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.36 97.03 1.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 110.898 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.35 178.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 66.51 88.03 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.464 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 51.0 m -157.37 64.72 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.865 0.364 . . . . 0.0 110.846 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.03 139.94 33.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -151.24 114.51 0.65 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 131.09 -46.34 1.08 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.505 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 52.11 54.99 9.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.916 0.389 . . . . 0.0 110.905 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -91.26 156.14 43.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.58 0.705 . . . . 0.0 110.931 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -25.27 28.99 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 0.0 112.365 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -84.96 101.12 12.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.954 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 31.7 ttp85 -137.83 111.16 7.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -66.7 129.49 40.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -91.78 -9.32 44.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -76.38 -36.96 57.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.15 -32.76 4.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.96 46.63 2.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -108.54 -179.38 3.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.32 141.4 33.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.066 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.581 ' CE1' HD13 ' A' ' 211' ' ' LEU . 15.2 m-85 -134.13 153.51 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.15 -28.47 25.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -123.52 162.78 22.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -53.1 9.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.97 -46.3 26.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 m -51.63 -38.6 55.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.87 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.581 HD13 ' CE1' ' A' ' 205' ' ' PHE . 9.7 tp -71.42 -32.26 68.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.955 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.539 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.5 mt -60.95 -32.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.404 ' O ' HG12 ' A' ' 213' ' ' VAL . 20.6 t -77.9 -10.74 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.722 ' O ' HG22 ' A' ' 217' ' ' VAL . 12.7 t60 -94.05 -32.51 13.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 212' ' ' ILE . 55.4 mt -56.72 -21.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.184 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -55.09 -26.14 35.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.5 m -82.51 -26.07 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -95.96 -74.07 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.12 151.0 24.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.153 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.79 103.11 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.61 126.61 50.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 110.842 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 52.11 -172.85 0.28 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.514 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 145.77 58.39 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.651 2.234 . . . . 0.0 112.369 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 3.1 p -157.59 34.7 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.81 -172.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 CA-C-O 119.132 -0.816 . . . . 0.0 112.501 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.74 113.43 10.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.906 0.384 . . . . 0.0 110.874 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.56 136.32 2.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.885 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -141.56 -130.9 2.6 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.503 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.29 -26.93 17.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.369 . . . . 0.0 110.915 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.1 m 52.27 41.81 30.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.81 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.51 -93.93 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.493 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -139.14 143.82 14.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.482 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -131.72 168.97 16.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.93 0.395 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -105.29 155.37 37.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.713 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -24.42 29.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.232 . . . . 0.0 112.367 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -86.49 100.71 12.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -136.48 111.39 8.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.5 t -67.43 129.93 41.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.52 -9.31 41.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.838 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -76.12 -36.68 58.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.06 -32.72 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.15 50.23 1.94 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.75 -179.01 3.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.11 140.21 34.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.604 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.5 m-85 -131.02 151.45 51.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.942 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.79 -29.25 29.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.823 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -123.19 164.91 17.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.17 -53.05 8.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.11 -45.73 26.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.49 -39.4 57.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.844 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.604 HD13 ' CE1' ' A' ' 205' ' ' PHE . 12.2 tp -71.03 -32.9 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.53 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.8 mt -60.03 -32.45 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.0 t -79.12 -10.88 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.717 ' O ' HG22 ' A' ' 217' ' ' VAL . 15.1 t60 -94.01 -32.88 13.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.862 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.53 HD12 ' HA ' ' A' ' 212' ' ' ILE . 58.0 mt -56.39 -21.76 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -55.21 -25.93 36.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.2 m -82.42 -25.6 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -97.66 -74.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.45 150.99 24.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.184 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.49 103.12 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.501 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.1 t -123.15 148.73 45.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.951 0.405 . . . . 0.0 110.8 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 73.52 172.97 25.76 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.444 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 96.76 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.733 2.289 . . . . 0.0 112.339 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 4.2 m -116.17 163.2 16.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.822 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 2.9 t -152.72 -42.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.843 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.469 -179.958 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.11 80.53 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.896 0.379 . . . . 0.0 110.901 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 67.3 m -123.02 161.76 23.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.839 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 176.35 -140.7 5.17 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.467 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 m 51.95 64.31 1.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 110.881 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.6 p -139.54 56.07 1.66 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.816 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 108.15 160.58 20.51 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.437 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 167.99 79.27 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.484 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.33 -26.85 9.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.861 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -84.08 155.64 63.89 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.552 0.691 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -24.74 29.69 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 0.0 112.368 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -86.02 100.61 12.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -136.75 111.31 8.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.8 130.65 43.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -92.48 -10.22 38.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.865 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -75.64 -36.94 60.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.88 -32.9 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.17 47.84 2.34 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -110.09 -179.2 3.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.799 0.333 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.66 140.12 34.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.079 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.6 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.4 m-85 -131.84 151.68 51.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.4 -29.03 28.48 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.831 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -123.18 164.77 18.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -53.08 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.23 -45.55 27.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.537 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.63 -39.38 57.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.848 0.356 . . . . 0.0 110.835 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.6 HD13 ' CE1' ' A' ' 205' ' ' PHE . 11.5 tp -71.01 -32.91 69.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.549 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.7 mt -60.0 -32.62 50.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.2 t -78.83 -10.79 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.094 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.719 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.2 t60 -94.18 -32.35 13.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 212' ' ' ILE . 56.0 mt -56.45 -21.68 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -55.52 -25.73 39.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.1 m -82.5 -24.88 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -98.5 -74.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.73 151.08 24.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.105 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.25 103.19 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 44.2 t -122.99 47.77 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.913 0.387 . . . . 0.0 110.869 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -92.98 -167.51 38.95 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -34.8 13.67 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.648 2.232 . . . . 0.0 112.357 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 60.2 m -156.56 -51.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.01 108.85 1.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.842 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.506 179.984 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.89 136.98 52.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 0.0 110.902 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 55.4 m -72.06 -50.56 27.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.872 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.81 142.76 5.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.535 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.9 t -69.04 147.77 51.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 0.0 110.871 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.6 m -112.82 49.08 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.85 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 85.34 175.46 50.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.494 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.63 70.76 1.0 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.477 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.11 112.37 23.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.956 0.408 . . . . 0.0 110.849 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -112.62 155.5 43.78 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.543 0.687 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -24.58 29.39 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.685 2.257 . . . . 0.0 112.36 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -86.19 100.63 12.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -136.04 111.3 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.851 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -67.32 130.15 42.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -92.5 -9.26 42.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -76.43 -37.44 57.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.43 -32.77 4.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.04 49.81 2.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.91 -179.05 3.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 0.0 110.935 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.82 139.75 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.596 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.2 m-85 -130.61 151.43 51.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 83.7 p -83.1 -28.93 29.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.78 163.8 20.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.937 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -76.03 -53.12 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.84 -45.87 25.25 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.455 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.52 -39.11 57.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 0.0 110.808 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.596 HD13 ' CE1' ' A' ' 205' ' ' PHE . 12.3 tp -71.36 -33.34 69.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.7 mt -59.68 -32.08 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 20.7 t -79.78 -10.87 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.724 ' O ' HG22 ' A' ' 217' ' ' VAL . 15.4 t60 -94.04 -33.19 13.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 212' ' ' ILE . 55.8 mt -56.51 -21.69 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -55.36 -25.86 37.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.1 m -82.72 -25.09 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -97.53 -74.19 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.0 151.11 26.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.05 103.16 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.9 t -118.82 -34.96 3.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 0.0 110.873 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -143.07 165.69 26.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 93.83 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.674 2.25 . . . . 0.0 112.349 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 45.9 m -133.96 27.47 3.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 3.5 m 52.11 34.84 15.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 CA-C-O 119.118 -0.823 . . . . 0.0 112.516 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.1 97.3 9.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.856 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.21 128.53 6.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.846 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 141.84 50.73 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.456 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.3 p -130.15 27.88 5.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 0.0 110.893 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.1 m -101.41 173.9 6.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.907 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -104.11 -78.25 1.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.481 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 112.23 41.98 1.02 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.489 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -102.15 -27.72 12.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.943 0.401 . . . . 0.0 110.882 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -75.79 154.8 85.2 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.579 0.704 . . . . 0.0 110.889 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -24.51 29.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 0.0 112.355 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -86.5 100.54 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.43 111.34 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.5 t -67.47 130.18 42.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -92.56 -9.91 39.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -75.51 -36.6 60.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.17 -32.76 4.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.04 50.11 1.97 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -113.59 -179.02 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.85 140.37 34.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.075 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.605 ' CE1' HD13 ' A' ' 211' ' ' LEU . 17.1 m-85 -131.07 151.42 51.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 38.7 t -83.05 -29.03 29.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -123.17 164.8 18.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -53.22 8.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.921 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.28 -45.32 28.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.49 -39.67 58.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.877 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.605 HD13 ' CE1' ' A' ' 205' ' ' PHE . 12.7 tp -70.89 -33.13 70.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.915 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.524 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.3 mt -59.7 -32.54 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.1 t -79.23 -10.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.718 ' O ' HG22 ' A' ' 217' ' ' VAL . 15.0 t60 -94.02 -32.64 13.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.856 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 212' ' ' ILE . 59.0 mt -56.41 -21.79 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -55.4 -25.79 37.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 214' ' ' HIS . 9.6 m -82.43 -25.08 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -98.48 -74.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.02 151.08 22.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.162 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.33 103.15 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.514 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.3 t -130.94 26.4 4.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.38 . . . . 0.0 110.833 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -111.28 165.76 12.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -48.26 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.64 2.227 . . . . 0.0 112.34 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.27 94.43 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.82 -47.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.834 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.092 -0.838 . . . . 0.0 112.504 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.0 m -80.91 127.56 32.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.3 p -164.7 -175.66 3.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.835 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -165.72 147.21 11.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 31.5 m -97.19 -67.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.878 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.5 m 57.56 72.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 170.89 83.99 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.491 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 157.46 98.57 0.15 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.468 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.29 -25.98 9.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.921 0.391 . . . . 0.0 110.898 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -81.73 155.39 70.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.56 0.695 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -23.99 29.94 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.693 2.262 . . . . 0.0 112.339 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -86.91 103.59 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -138.05 110.59 7.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -66.5 130.38 42.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.48 -9.29 41.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.852 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -76.66 -37.39 56.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -119.66 -32.94 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.81 49.02 2.19 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.455 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -111.67 -178.97 3.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.36 141.18 35.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.09 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.591 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.7 m-85 -132.32 151.35 51.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.15 -28.98 29.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -123.31 163.72 20.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -53.16 8.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.29 -45.57 28.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.3 m -51.52 -39.24 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.862 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.591 HD13 ' CE1' ' A' ' 205' ' ' PHE . 11.3 tp -71.16 -33.07 69.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.958 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.1 mt -59.89 -32.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.089 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.1 t -79.35 -10.87 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.724 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.5 t60 -94.17 -32.33 13.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.832 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 212' ' ' ILE . 58.7 mt -56.8 -21.56 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.108 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -55.4 -25.72 37.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.3 m -82.77 -24.96 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.079 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -98.34 -75.0 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.91 151.1 24.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.11 103.08 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.5 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.1 t -123.91 46.55 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.827 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 162.94 -75.64 0.18 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.478 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 97.49 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.674 2.25 . . . . 0.0 112.385 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 13.7 m -104.8 39.57 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.1 t -91.43 -32.45 15.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.873 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.516 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.4 p -146.36 154.63 41.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.88 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.6 p -153.41 172.01 17.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 106.62 -142.06 15.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.44 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.3 t 56.99 86.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.836 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.91 157.52 43.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.77 -100.71 0.18 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.499 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 103.8 101.39 2.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.488 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -119.94 -44.49 2.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.953 0.406 . . . . 0.0 110.908 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -107.35 155.03 40.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.571 0.701 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -24.06 30.06 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.642 2.228 . . . . 0.0 112.394 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -87.14 100.26 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -135.05 111.36 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -67.25 130.37 42.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.49 -9.29 41.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -76.6 -37.7 56.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.17 -32.8 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.41 50.45 2.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.458 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.58 -178.99 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.49 139.52 35.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.606 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.2 m-85 -130.01 149.91 51.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 98.1 p -81.41 -29.57 33.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.19 164.49 18.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -76.55 -53.74 7.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.64 -45.68 23.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.493 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.3 m -51.5 -38.74 55.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.942 0.401 . . . . 0.0 110.887 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.606 HD13 ' CE1' ' A' ' 205' ' ' PHE . 15.0 tp -72.23 -32.83 67.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.518 ' HA ' HD12 ' A' ' 215' ' ' ILE . 18.3 mt -60.34 -30.63 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.8 t -81.39 -10.84 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.718 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.5 t60 -93.63 -32.85 13.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 212' ' ' ILE . 54.6 mt -56.66 -21.57 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -54.93 -26.0 33.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.7 m -82.45 -26.56 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -96.51 -74.82 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.12 150.97 23.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.65 103.27 0.1 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.452 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.42 25.19 7.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.96 0.41 . . . . 0.0 110.845 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -175.85 166.17 37.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.446 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -173.4 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.696 2.264 . . . . 0.0 112.337 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 59.9 m 53.92 28.03 8.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.5 m -54.32 148.0 12.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.494 -179.993 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 4.5 m 61.41 -170.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.357 . . . . 0.0 110.884 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 7.7 t -169.77 -59.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 102.61 140.93 11.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.4 t -159.23 -179.09 7.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.35 160.09 32.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -155.0 -110.89 0.38 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.508 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.0 26.6 69.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.439 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -82.55 -62.8 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.926 0.393 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -96.02 154.6 38.87 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.518 0.675 . . . . 0.0 110.901 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -23.55 30.64 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.708 2.272 . . . . 0.0 112.309 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -87.72 100.34 12.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.79 111.45 9.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -67.54 129.89 41.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.46 -9.24 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -76.23 -36.87 58.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.04 -32.84 4.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 95.85 50.53 1.93 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -178.83 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.333 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.06 140.04 34.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.067 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.622 ' CE1' HD13 ' A' ' 211' ' ' LEU . 15.5 m-85 -129.99 150.16 51.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.83 -29.59 35.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -123.26 165.37 17.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -52.78 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.31 -45.57 28.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.52 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.69 -38.84 56.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.862 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.622 HD13 ' CE1' ' A' ' 205' ' ' PHE . 12.4 tp -71.5 -32.56 68.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.93 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.435 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.0 mt -60.45 -32.27 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.3 t -80.2 -10.7 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.744 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.7 t60 -92.93 -33.87 14.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 212' ' ' ILE . 55.0 mt -58.23 -20.49 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -55.27 -25.42 33.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 214' ' ' HIS . 11.5 m -85.24 -24.89 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.121 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -93.86 -74.71 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.12 150.94 23.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.139 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.64 102.85 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.504 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.67 -26.27 7.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 0.0 110.857 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -157.56 -75.54 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.47 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 88.38 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.688 2.258 . . . . 0.0 112.389 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.49 152.57 45.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.859 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.1 t 57.9 -173.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 CA-C-O 119.153 -0.804 . . . . 0.0 112.504 -179.976 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.13 -49.42 6.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.902 0.382 . . . . 0.0 110.905 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.34 92.27 3.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -154.52 -58.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.47 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 m 54.25 77.55 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.8 p -129.96 135.48 48.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 112.04 -110.29 2.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.47 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -163.16 110.52 0.43 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.487 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -99.36 131.3 45.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.903 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.79 153.73 55.27 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.592 0.71 . . . . 0.0 110.93 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -15.99 37.16 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.677 2.251 . . . . 0.0 112.32 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -95.52 99.73 11.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -135.09 111.64 9.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -66.94 131.19 45.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -92.45 -13.2 30.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -72.21 -36.47 69.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.7 p -120.21 -32.76 4.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 94.54 50.81 2.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.472 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -114.12 -179.24 3.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.771 0.32 . . . . 0.0 110.926 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -138.79 137.77 36.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.618 ' CE1' HD13 ' A' ' 211' ' ' LEU . 18.4 m-85 -127.87 144.85 51.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.8 t -75.83 -31.28 59.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -123.12 164.87 17.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -76.25 -52.59 9.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.2 -45.17 27.48 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.499 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -39.49 58.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.848 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.618 HD13 ' CE1' ' A' ' 205' ' ' PHE . 13.9 tp -71.1 -33.79 70.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.503 ' HA ' HD12 ' A' ' 215' ' ' ILE . 15.7 mt -58.89 -31.92 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.6 t -80.98 -10.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.169 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.709 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.0 t60 -93.42 -31.9 14.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 212' ' ' ILE . 58.2 mt -56.34 -21.98 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -55.51 -25.64 38.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 214' ' ' HIS . 9.0 m -81.98 -25.62 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -98.69 -74.95 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.846 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.54 150.99 22.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.87 103.16 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.457 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.4 t -129.32 161.86 29.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.39 . . . . 0.0 110.809 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 109.82 -175.16 18.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.48 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -28.37 25.2 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.66 2.24 . . . . 0.0 112.357 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 63.6 p -151.26 136.45 17.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.831 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.22 171.69 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.823 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.461 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.8 t -105.38 125.44 50.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.836 0.35 . . . . 0.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 55.2 p -86.37 -178.04 6.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.839 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -171.53 84.73 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.467 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.18 164.93 25.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 74.7 m -97.06 159.76 14.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -131.55 -125.46 2.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -107.68 159.78 14.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.511 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.29 119.95 19.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.371 . . . . 0.0 110.92 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.64 153.68 37.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.615 0.721 . . . . 0.0 110.856 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -15.63 37.06 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.658 2.239 . . . . 0.0 112.367 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -96.65 99.6 11.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.79 111.59 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.87 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.7 t -67.44 131.08 44.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -92.42 -12.64 31.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -72.78 -36.86 67.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.8 p -119.93 -32.57 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.854 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 94.52 50.88 2.09 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -114.09 -179.27 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.04 136.44 33.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.604 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.3 m-85 -126.52 146.97 49.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.59 -30.64 52.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.59 165.36 16.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -52.92 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.21 -45.38 27.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.467 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.55 -39.55 57.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.902 0.382 . . . . 0.0 110.82 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.604 HD13 ' CE1' ' A' ' 205' ' ' PHE . 14.2 tp -70.99 -33.16 70.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.495 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.5 mt -59.6 -32.37 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 213' ' ' VAL . 21.0 t -80.38 -10.73 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.717 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.2 t60 -93.26 -32.16 14.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 212' ' ' ILE . 58.6 mt -56.58 -21.78 13.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -55.5 -25.71 38.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 214' ' ' HIS . 9.5 m -82.3 -25.03 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.132 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -98.95 -75.07 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 m -101.37 151.01 22.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.54 103.12 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.558 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.8 t -130.74 26.53 5.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.955 0.407 . . . . 0.0 110.863 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -156.72 -74.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 141.4 45.26 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.691 2.26 . . . . 0.0 112.389 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.1 -31.37 65.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.5 t -123.78 149.74 45.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 CA-C-O 119.181 -0.788 . . . . 0.0 112.476 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.5 m -144.63 147.36 33.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.891 0.376 . . . . 0.0 110.877 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.55 94.04 3.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.823 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -137.29 38.67 1.71 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.481 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.62 133.25 52.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 0.0 110.881 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.35 -58.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 73.93 41.83 39.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.517 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.18 -24.13 52.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.455 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -55.82 -71.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.964 0.411 . . . . 0.0 110.94 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -115.13 155.72 46.33 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.562 0.696 . . . . 0.0 110.938 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.77 -24.82 29.2 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.675 2.25 . . . . 0.0 112.309 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -85.73 100.62 12.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -136.12 111.43 9.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 10.1 t -67.76 130.35 42.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.34 -10.16 39.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -75.28 -36.67 61.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.33 -33.1 3.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.54 48.42 2.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -111.34 -178.8 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.788 0.328 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.71 139.11 32.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.592 ' CE1' HD13 ' A' ' 211' ' ' LEU . 15.5 m-85 -130.14 152.65 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 27.4 t -83.77 -29.04 27.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -123.41 163.86 20.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.3 -52.66 9.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -48.11 -46.23 27.0 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 m -51.66 -38.62 55.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.592 HD13 ' CE1' ' A' ' 205' ' ' PHE . 11.6 tp -71.43 -32.17 68.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.7 mt -60.95 -33.03 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.3 t -79.11 -10.8 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.749 ' O ' HG22 ' A' ' 217' ' ' VAL . 14.8 t60 -93.32 -36.48 12.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.75 -19.92 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -23.92 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 214' ' ' HIS . 11.5 m -87.75 -23.8 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -91.14 -74.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.1 m -104.55 151.2 23.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.0 103.07 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.25 -62.87 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.818 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -101.68 168.26 19.35 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.452 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -22.19 32.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.638 2.225 . . . . 0.0 112.325 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 24.2 p -108.61 137.67 46.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 73.1 m 58.45 94.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.459 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.1 92.85 4.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 110.879 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 78.0 p -152.28 149.6 28.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.856 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -68.26 -132.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.459 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.65 135.14 14.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.916 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.8 p -84.33 -55.58 4.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 153.57 -66.45 0.32 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.506 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.9 109.4 0.48 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.55 -34.19 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.376 . . . . 0.0 110.869 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.6 156.54 47.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.578 0.704 . . . . 0.0 110.922 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -26.09 28.13 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.706 2.27 . . . . 0.0 112.339 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -85.14 104.21 14.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.877 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 108.75 5.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.1 t -65.34 130.7 44.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.51 -9.74 40.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -76.37 -36.91 57.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.17 -32.89 4.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.4 39.31 3.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.518 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.28 -179.99 4.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 0.0 110.872 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.18 138.46 28.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.55 ' CE1' HD13 ' A' ' 211' ' ' LEU . 10.5 m-85 -133.21 163.96 28.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.7 m -101.9 -21.77 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.855 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -123.58 138.94 54.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -56.53 20.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.68 -45.13 24.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.504 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.41 -39.79 58.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.888 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 211' ' ' LEU . 9.3 tp -71.38 -32.4 68.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.582 ' HA ' HD12 ' A' ' 215' ' ' ILE . 17.3 mt -60.89 -31.77 50.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.137 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 213' ' ' VAL . 20.9 t -78.33 -10.97 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.718 ' O ' HG22 ' A' ' 217' ' ' VAL . 11.7 t60 -94.55 -31.32 13.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 212' ' ' ILE . 56.5 mt -56.71 -21.59 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.1 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -55.48 -25.82 39.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.2 m -82.17 -25.14 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -98.59 -74.92 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.2 m -104.71 151.07 24.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.27 103.2 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.484 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.0 t -123.15 46.95 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 110.898 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -170.79 67.28 0.15 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.509 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 165.23 31.66 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.68 2.253 . . . . 0.0 112.311 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.1 m 61.89 166.79 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.9 t 61.78 167.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 CA-C-O 119.125 -0.82 . . . . 0.0 112.504 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 50.7 m -96.62 55.55 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 110.873 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.0 t -52.38 -37.02 55.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.898 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 73.37 101.81 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.53 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.6 p -70.89 142.59 51.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 110.894 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 64.7 p -176.46 -177.61 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 128.84 137.31 4.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.53 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.34 -150.71 2.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -131.24 24.06 4.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -115.87 155.72 47.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.589 0.709 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -28.31 25.33 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.71 2.273 . . . . 0.0 112.305 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -82.8 104.58 13.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.36 109.13 5.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.0 130.42 43.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.4 -9.46 41.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -76.6 -36.88 57.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.19 -32.87 4.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.27 40.65 3.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.517 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -101.31 -179.71 4.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.19 139.21 28.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.098 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.55 ' CE1' HD13 ' A' ' 211' ' ' LEU . 11.2 m-85 -133.43 164.44 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.2 m -102.45 -21.65 14.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -123.6 139.57 53.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.94 -56.93 15.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.71 -44.82 23.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.443 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.5 m -51.44 -40.23 58.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.905 0.384 . . . . 0.0 110.825 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 211' ' ' LEU . 9.0 tp -71.05 -32.62 69.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.572 ' HA ' HD12 ' A' ' 215' ' ' ILE . 16.9 mt -60.67 -31.8 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.2 t -78.29 -10.98 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.148 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.728 ' O ' HG22 ' A' ' 217' ' ' VAL . 11.6 t60 -94.54 -31.38 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 212' ' ' ILE . 56.6 mt -57.17 -21.34 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.12 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -55.52 -26.03 40.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.3 m -82.34 -24.53 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.155 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -98.43 -74.71 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.47 151.2 25.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -50.86 103.2 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.509 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 17.7 t -117.02 68.45 0.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.909 0.385 . . . . 0.0 110.811 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 151.79 168.03 15.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.454 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 84.17 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 6.8 p -53.88 -32.49 53.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.02 46.06 27.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.848 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 CA-C-O 119.153 -0.804 . . . . 0.0 112.461 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 28.9 t -80.53 80.59 6.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 110.865 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 22.8 t -138.62 101.67 4.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 172.28 38.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.457 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t -80.4 93.12 5.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.917 0.389 . . . . 0.0 110.894 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.0 m -150.11 152.96 35.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.844 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 52.18 85.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -153.77 117.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.465 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -175.13 -36.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.368 . . . . 0.0 110.877 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.32 155.35 92.64 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.62 0.724 . . . . 0.0 110.879 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -27.24 26.97 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.698 2.265 . . . . 0.0 112.38 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -84.13 105.04 14.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -142.53 106.56 4.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.885 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -63.43 129.39 40.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -91.08 -9.4 45.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.56 -37.01 57.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.11 -32.86 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.21 38.81 3.93 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.489 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -98.29 -179.73 4.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 0.0 110.903 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -143.86 138.8 28.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.082 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.538 ' CE1' HD13 ' A' ' 211' ' ' LEU . 12.6 m-85 -133.93 164.15 27.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 5.1 m -102.44 -21.36 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -124.22 141.29 52.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -56.91 16.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.52 -44.96 22.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.519 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.47 -39.95 58.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 110.83 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 211' ' ' LEU . 9.5 tp -71.41 -32.27 68.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.93 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.574 ' HA ' HD12 ' A' ' 215' ' ' ILE . 17.9 mt -61.15 -31.64 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.8 t -78.54 -10.96 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.075 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.722 ' O ' HG22 ' A' ' 217' ' ' VAL . 10.6 t60 -94.19 -31.2 14.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 212' ' ' ILE . 54.8 mt -57.15 -21.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.092 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.7 mtt-85 -55.47 -25.92 39.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.829 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.0 m -82.35 -25.13 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.131 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -97.56 -74.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.03 151.19 26.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.14 103.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.9 t -118.92 144.63 46.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 0.0 110.903 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 166.18 -174.93 41.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.438 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 146.97 62.09 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.702 2.268 . . . . 0.0 112.343 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 11.3 m 63.03 -177.63 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 88.9 p -104.93 57.96 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 CA-C-O 119.157 -0.802 . . . . 0.0 112.479 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.5 t -171.08 93.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 0.0 110.844 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.67 168.53 13.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -168.01 77.28 0.11 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 42.1 p -117.5 156.36 28.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.845 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.3 t -153.21 157.34 40.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 111.99 170.14 18.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.498 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 128.62 57.4 0.11 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.466 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.12 -28.88 13.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 0.0 110.856 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.73 156.24 35.48 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.595 0.712 . . . . 0.0 110.89 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -25.15 29.01 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.705 2.27 . . . . 0.0 112.326 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -86.27 103.82 15.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -141.68 107.19 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 12.3 t -64.9 129.06 38.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.924 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.33 -11.93 39.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -73.0 -37.36 67.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -120.24 -32.93 4.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.6 38.56 3.9 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -98.06 -179.97 4.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.8 137.73 26.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.056 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.575 ' CE1' HD13 ' A' ' 211' ' ' LEU . 9.8 m-85 -133.04 164.06 27.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.98 -21.67 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -123.07 138.81 54.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -56.97 15.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.43 -45.65 22.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.45 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -51.63 -38.09 53.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 110.842 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.575 HD13 ' CE1' ' A' ' 205' ' ' PHE . 14.0 tp -73.24 -31.02 63.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.435 ' HA ' HD12 ' A' ' 215' ' ' ILE . 18.7 mt -62.88 -30.27 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.0 t -80.03 -10.85 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.749 ' O ' HG22 ' A' ' 217' ' ' VAL . 9.6 t60 -93.46 -33.24 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 212' ' ' ILE . 55.4 mt -59.39 -19.79 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -55.45 -25.0 33.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 214' ' ' HIS . 12.8 m -86.13 -24.54 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -92.33 -75.05 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.98 151.01 22.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.147 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.66 102.99 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.47 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.41 102.19 9.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.927 0.394 . . . . 0.0 110.866 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 62.0 166.82 0.52 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.481 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 172.81 11.93 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.318 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 49.4 m -154.29 151.58 29.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 50.7 m -73.71 -49.63 24.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 119.182 -0.788 . . . . 0.0 112.524 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 67.1 p -166.15 -179.44 5.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.885 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.7 t -135.93 91.51 2.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.797 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -147.73 161.67 28.58 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.473 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 62.1 m -68.47 -26.31 65.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.902 0.382 . . . . 0.0 110.871 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 m 63.16 92.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.86 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.63 -150.7 19.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.5 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 140.98 132.93 2.88 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.454 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.1 53.7 1.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.946 0.403 . . . . 0.0 110.882 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -106.45 156.5 36.91 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.549 0.69 . . . . 0.0 110.859 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -26.19 27.56 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.674 2.249 . . . . 0.0 112.349 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -83.59 101.74 11.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -136.87 111.26 8.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.93 126.09 28.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -88.34 -10.93 47.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -73.01 -38.81 66.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.77 -33.15 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.5 48.1 2.05 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -111.66 -178.64 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -141.2 140.53 34.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.644 ' CE1' HD13 ' A' ' 211' ' ' LEU . 15.9 m-85 -131.77 153.6 49.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.9 m -87.33 -27.09 23.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -123.58 157.05 34.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -54.68 10.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.97 -45.58 26.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.497 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.5 m -51.98 -36.29 49.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.839 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.644 HD13 ' CE1' ' A' ' 205' ' ' PHE . 13.2 tp -74.86 -31.75 61.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.7 mt -62.65 -27.6 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.26 -10.73 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.09 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.761 ' O ' HG22 ' A' ' 217' ' ' VAL . 9.1 t60 -93.9 -36.8 12.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.58 -19.87 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.154 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -59.42 -20.7 57.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 214' ' ' HIS . 5.9 m -98.02 8.11 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -114.8 -75.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.85 90.71 3.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 51.29 -106.98 0.34 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.485 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.76 88.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.38 . . . . 0.0 110.844 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.09 75.58 1.31 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 125.73 12.48 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.655 2.237 . . . . 0.0 112.36 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 74.5 p -123.76 164.26 19.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.83 36.38 4.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.859 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 119.106 -0.83 . . . . 0.0 112.499 -179.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.16 -26.98 14.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.914 0.388 . . . . 0.0 110.887 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m 62.93 -177.57 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.878 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 103.06 47.77 1.31 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.463 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.46 149.83 23.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.925 0.393 . . . . 0.0 110.794 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 82.1 p -103.94 74.54 1.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.853 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -102.42 -95.81 2.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.504 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 55.11 68.79 1.5 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.491 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -102.11 -26.52 13.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.391 . . . . 0.0 110.884 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.25 155.72 74.34 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.571 0.7 . . . . 0.0 110.872 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -26.7 27.57 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.738 2.292 . . . . 0.0 112.367 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -84.74 106.36 16.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -142.94 107.0 4.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.4 t -64.53 130.15 42.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.858 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -92.04 -9.52 42.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.847 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -76.44 -36.88 57.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.946 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 26.9 p -120.32 -32.85 4.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 98.01 39.83 3.7 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.481 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -100.31 -179.82 4.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.1 140.08 29.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.085 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.529 ' CE1' HD13 ' A' ' 211' ' ' LEU . 12.1 m-85 -134.08 163.87 28.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 71.0 m -100.68 -22.42 14.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.819 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -123.43 144.26 49.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.416 ' HD2' HD11 ' A' ' 212' ' ' ILE . 2.3 tmtm? -61.46 -57.29 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -46.94 -44.31 18.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.463 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.5 m -51.63 -40.01 59.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 110.872 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.529 HD13 ' CE1' ' A' ' 205' ' ' PHE . 10.5 tp -72.0 -32.86 67.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.475 ' HA ' HD12 ' A' ' 215' ' ' ILE . 17.9 mt -60.99 -29.43 45.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 213' ' ' VAL . 19.9 t -81.53 -10.81 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.74 ' O ' HG22 ' A' ' 217' ' ' VAL . 10.1 t60 -94.35 -33.66 13.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 212' ' ' ILE . 54.9 mt -57.92 -20.61 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -55.33 -25.26 33.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 214' ' ' HIS . 11.4 m -84.5 -25.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -93.09 -74.71 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.24 151.03 24.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.4 102.9 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.47 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.97 -26.1 7.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 110.84 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -161.84 165.7 35.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -171.15 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.685 2.256 . . . . 0.0 112.332 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 16.5 p -97.95 87.5 4.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.9 p -87.43 -63.07 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.903 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 119.124 -0.82 . . . . 0.0 112.476 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.4 m -120.07 94.88 4.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 0.0 110.855 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.55 -170.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.842 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 147.57 141.38 3.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.8 p -146.57 177.58 8.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.89 0.376 . . . . 0.0 110.87 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.2 p -170.38 152.06 3.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.892 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.37 30.57 8.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.541 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 178.36 119.72 0.62 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.475 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -138.35 137.57 37.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 110.899 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -66.13 155.37 87.63 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.524 0.678 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -25.16 28.79 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.672 2.248 . . . . 0.0 112.349 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -85.81 99.95 11.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -135.09 111.57 9.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.2 t -68.71 128.04 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.57 -12.43 39.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.81 -38.55 70.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.1 p -118.82 -32.94 4.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 96.08 50.35 1.93 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.86 -178.56 3.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.792 0.329 . . . . 0.0 110.928 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.7 139.18 34.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.073 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.592 ' CE1' HD13 ' A' ' 211' ' ' LEU . 17.2 m-85 -129.48 150.71 50.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 56.0 p -82.89 -28.78 29.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.65 162.41 23.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -53.85 8.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.7 -46.07 24.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.482 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.4 m -51.36 -37.58 48.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.901 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.592 HD13 ' CE1' ' A' ' 205' ' ' PHE . 15.0 tp -73.7 -31.7 63.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.928 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 18.9 mt -61.93 -29.11 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 213' ' ' VAL . 19.8 t -83.43 -10.88 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.753 ' O ' HG22 ' A' ' 217' ' ' VAL . 10.0 t60 -95.09 -40.32 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 53.1 mt -57.79 -20.46 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -59.26 -21.19 59.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 214' ' ' HIS . 5.4 m -97.46 7.45 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -113.25 -74.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 50.4 m -119.18 90.86 3.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 51.85 -107.19 0.42 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.494 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.75 88.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.938 0.399 . . . . 0.0 110.85 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 90.49 173.07 44.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.471 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 138.45 37.89 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.714 2.276 . . . . 0.0 112.387 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 70.4 m -101.75 90.71 4.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.4 m -116.4 -57.76 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.829 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 119.159 -0.801 . . . . 0.0 112.507 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 47.0 m -88.87 -45.13 9.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.936 0.398 . . . . 0.0 110.884 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.4 t -126.42 -45.52 1.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.841 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 142.95 66.09 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.503 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 61.8 p -145.91 176.52 9.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 110.85 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.2 m -115.17 -32.73 5.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.831 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -86.42 -134.03 3.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.461 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -137.29 162.92 25.41 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.463 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -53.74 -62.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 110.889 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -115.85 154.56 48.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.587 0.708 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -26.86 27.04 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.708 2.272 . . . . 0.0 112.33 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.19 110.53 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -144.94 104.38 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.3 t -62.9 127.25 30.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.58 -9.25 50.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -76.35 -37.26 57.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -120.36 -32.98 3.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.37 41.55 3.41 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -102.19 -179.35 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.341 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -143.11 142.28 31.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.476 ' CE1' HD13 ' A' ' 211' ' ' LEU . 14.7 m-85 -135.86 162.5 32.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.0 -23.19 16.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -125.82 150.9 47.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.941 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -54.34 24.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.95 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.7 -46.26 24.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.447 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -51.29 -39.54 57.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 110.907 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 211' ' ' LEU . 9.6 tp -70.86 -32.03 68.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.951 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.527 ' HA ' HD12 ' A' ' 215' ' ' ILE . 17.0 mt -61.45 -31.94 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.091 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 213' ' ' VAL . 20.0 t -78.95 -10.84 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.71 ' O ' HG22 ' A' ' 217' ' ' VAL . 11.2 t60 -93.73 -31.89 14.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 212' ' ' ILE . 57.1 mt -56.7 -21.61 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.135 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -54.87 -26.22 34.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 214' ' ' HIS . 10.8 m -81.49 -27.12 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.116 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -96.39 -74.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.86 150.98 22.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.78 103.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.16 25.23 5.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.95 0.405 . . . . 0.0 110.866 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -174.31 -69.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.491 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 126.81 13.74 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.642 2.228 . . . . 0.0 112.392 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.28 -50.52 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.822 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 78.1 p -127.94 166.07 19.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 CA-C-O 119.12 -0.822 . . . . 0.0 112.5 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.98 98.42 3.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.86 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.9 p -133.8 125.43 28.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -149.83 -77.38 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.499 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.8 161.0 40.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.2 t -106.86 -56.42 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.849 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.91 147.65 6.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.61 142.16 41.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.449 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -55.99 -26.91 50.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -100.73 156.43 35.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.65 0.738 . . . . 0.0 110.885 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -27.13 26.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.671 2.248 . . . . 0.0 112.361 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -82.45 101.61 10.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -136.69 111.26 8.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 16.0 t -69.12 124.51 23.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.71 -11.16 52.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.41 -40.07 67.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.974 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.0 p -117.81 -33.2 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.81 48.12 1.99 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.518 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -111.63 -178.73 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -140.71 140.98 34.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.13 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.651 ' CE1' HD13 ' A' ' 211' ' ' LEU . 16.8 m-85 -132.24 153.22 50.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.3 p -86.5 -27.6 23.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.854 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -123.91 159.66 29.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -72.89 -54.5 8.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -47.8 -45.96 24.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.466 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.8 m -51.8 -36.24 47.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.917 0.389 . . . . 0.0 110.85 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.651 HD13 ' CE1' ' A' ' 205' ' ' PHE . 14.0 tp -74.92 -32.28 61.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.2 mt -62.36 -26.94 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 19.6 t -84.74 -10.8 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.76 ' O ' HG22 ' A' ' 217' ' ' VAL . 8.7 t60 -94.35 -36.74 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 54.8 mt -58.28 -20.03 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -59.32 -20.6 55.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 214' ' ' HIS . 5.8 m -98.38 10.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.127 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -117.11 -75.07 0.58 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.22 90.82 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 51.06 -108.51 0.56 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.507 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.09 26.08 7.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.851 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 179.32 -75.73 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.497 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 178.35 4.61 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.727 2.284 . . . . 0.0 112.369 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.07 143.24 27.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 17.3 p -81.05 -44.56 17.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 CA-C-O 119.144 -0.809 . . . . 0.0 112.453 179.999 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_